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ABSTRACT
NOVEL SOLID-PHASE EXTRACTION TECHNIQUES FOR BIOLOGICAL AND
ENVIRONMENTAL ANALYSIS USING ISOTOPE DILUTION MASS SPECTROMETRY

By
Andrew J. Boggess
May 2015

Dissertation supervised by Professor H.M. Skip Kingston
Awareness and study of the ways in which the environment can interact with the personal
genetics and epigenetics of an individual has grown substantially in recent years, resulting in the
field of Exposomics. In an era of increasingly personalized medicine, novel techniques are
necessary to ensure the accurate and sensitivity measurement of clinically and environmentally
relevant molecules in biological and environmental samples. Addressing existing shortcomings
cited in literature, methods were developed and optimized for the extraction, separation, mass
analysis, and quantification of a suite of environmental organic pollutants in both biological and
environmental samples, with the primary objective of improving accuracy, increasing sensitivity,
and reducing sample and reagent consumption. The secondary objective of this research was the
production of validated methods capable of inter-laboratory method transfer with minimal
training required in the receiving laboratory. Two novel methods have been developed,
optimized, validated, and applied to collaborative environmental research. These novel methods
iv

represented a demonstrative improvement upon existing methods in both analytical quality and
capability for inter-laboratory method transfer. Both developed methods were utilized in two
collaborative clinical research studies investigating the impact of environmentally-sources agents
on children diagnosed with autism spectrum disorders (ASD). The high-quality data obtained in
these studies yielded results that may have provided valuable insight into the development and
maintenance of autism spectrum disorders. These novel methods allowed for the discovery of a
first-of-its-kind variable in the children with ASD, compared with controls. This variable was
statistically predictive for the probability of an individual being diagnosed with the most
behaviorally severe autism disorder, with a statistically significant overall model fit. This novel
analytical method was then expanded in breadth through application to industrial and municipal
wastewater to aid in updating EPA Method 625 for wastewater analysis. Applying this novel
method to wastewater produced data of higher analytical quality, in both accuracy and precision,
compared with all other collaborative laboratories. The methods developed in this work for the
quantification of organic molecules implicated in environmental human health in biological and
environmental samples have significantly improved analytically upon existing methods and have
yielded clinically relevant findings in collaborative clinical research studies.
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Chapter 1: Introduction
1.1 Exposome and Exposomic Research
Emergent data has implicated environmental exposure, combined with genetics, as a
potential causative factor in the development of numerous disease states.1-5 The U.S. Centers for
Disease Control and Prevention and the U.S. National Institute for Occupational Safety and
Health have endorsed the term “exposomics” to foster an increased understanding of how
environmental exposure can interact with personal genetics, physiology, and epigenetics to
impact overall health.6 A link has been suggested between serum concentration of certain organic
pollutants and etiology of specific disease-states such as autism spectrum disorders, heart
disease, diabetes, obesity, and lupus, among many others.1,3,7-11 Taken collectively, these carbonbased toxins are known as persistent organic pollutants (POPs) and exhibit common
characteristics such as semi-volatility, environmental persistence, low water solubility and
inherent toxicity.12
In 2001, 178 countries and the European Union signed the Stockholm Convention on
POPs, which restricted or eliminated the production of certain chlorinated pesticides,
polychlorinated biphenyls (PCBs), polybrominated diphenyl ethers (PBDEs), and chlorinated
benzene compounds.13,

14

The World Health Organization has developed guidelines for

quantifying POPs in biological fluids to assess exposure.15 Increasing interest has been placed in
the development of methods to quantify POPs in serum and other biological and environmental
matrices for the purposes of improving environmental human health and disease diagnosis and
prevention.16-18 Understanding and defining the potential link between exposure to
environmental contaminants, such as POPs, and the individualized health of human beings is a
primary goal of exposomic research.19-21

1

One of the most studied disease-states in exposomic research is autism spectrum
disorders (ASD).22, 23 ASD are characterized behaviorally by impaired social communication and
interaction, and repetitive behaviors.

24

Recent studies have suggested the incidence of ASD is

increasing, 25, 26 but scholarly opinion remains divided on the mechanism governing the increase.
27

While studies have estimated that at least half of the causation of ASD is attributable to

genetic factors,

28

it has been suggested that increased risk of ASD-diagnosis may be associated

with increased exposure to environmental triggers.

29, 30

These studies have correlated maternal

exposure to environmental air pollutants and proximity to coal-fired power plants, pesticide-rich
agricultural fields, known toxic-chemical sites, and traffic-related air pollution with increased
rates of ASD.

31-36

Noting that environmental exposures typically occur in combination, not

isolation, researchers have recommended that greater focus be placed on examining the
combinative physiological effects of organic pollutants. 37
Figure 1.1 demonstrates the complex relationship that environmental pollutants have with
the systems of the human body.38-41 One of the objectives of exposomics is to bridge the many
disparate fields that separate the study of the numerous bodily systems to gain a more detailed
view of the interactions between the human body and its environment.

2

Figure 1.1:38-41 Demonstration of the interconnectivity of bodily systems and the broad effects of
common environmental pollutants
Beyond simply studying the effects of environmental pollutants, exposomic researchers
have focused on sourcing exposures, which has lead to the inter-field collaboration of many
differing research interests. In addition to biological fluids, researchers have studied such
disparate exposure routes as drinking water, ground water, air, soil, food, and household
environments. The isolation of an individual from his or her environment also has been used to
3

gauge the environmental effects on particular disease-state populations. Waters, particularly
drinking and wastewaters, are of interest to exposomic researchers, as these aqueous solutions
possess many similar chemo-physical characteristics as biological fluids.
Methods have been developed, and continue to be developed, to extract and quantify
decreasing concentrations of harmful environmental pollutants in biological fluids. In an era of
increasingly personalized medicine, it is reasonable to suggest that the prevalence of clinically
standard analytical tests for environmental pollutants will only increase as researchers continue
to learn more about the impact on human health caused by exposure to environmental pollutants.

1.2 Inter-Laboratory Analytical Method Transfer
It may not be feasible to expect all commercial, government, clinical, or academic
laboratories to reproduce validated, peer-reviewed methods to the same degree of high analytical
quality as the developing laboratory. To ensure that quality control parameters are met by the
method-receiving laboratories, regulatory bodies have instituted quality assurance / quality
control guidelines for inter-laboratory method transfer. The U.S. Pharmacopeia describes the
most common type of analytical method transfer: transfer of a validated method from a
developing laboratory (transferring laboratory) to an outside laboratory (receiving laboratory). 42
The most common method for validating the analytical quality of the receiving laboratory is by
comparative testing. Comparative testing is performed by the receiving laboratory by the
analysis of a sample intentionally prepared at a known concentration of select analyte(s) by the
transferring laboratory. Quantification of the prepared sample by the receiving laboratory to predetermined analytical quality (often measured by accuracy, precision, sensitivity, and selectivity)
is required to validate the QA/QC of the receiving laboratory. Further, the U.S. Food and Drug

4

Administration stipulates that the transfer validation must by verified under actual laboratory
conditions, including the sample matrix, instrumental parameters, and analysts that be present
when the actual samples are analyzed.43
To ensure the adoption of developed high-quality analytical methods by outside
laboratories, it is important to limit the number of highly complex sample preparation steps and
to reduce the influence of analyst skill on final quantitative quality. Much of the research
described herein focused on producing methods capable of being replicated by outside
laboratories with only minimal additional training. This objective was accomplished using
extraction technologies and quantitative procedures that improved sensitivity, selectivity, and
reproducibility to correct for many common sources of analytical error.

1.3 Isotope Dilution Mass Spectrometry
Quantification by isotope dilution mass spectrometry (IDMS) is based on spiking of
known amounts of enriched isotopic analogs of each compound into a sample. Prior to
extraction, equilibrium must be obtained between the endogenous and labeled isotopic
compounds. With the known isotopic abundance of both endogenous and isotopically labeled
analytes, the amount of spike added to the known amount of sample, concentration of the spike
added, and altered isotopic ratio, the concentration of the endogenous molecule in the sample can
be directly calculated.44 The method of IDMS eliminates calibration curves and correction
factors by avoiding internal standards that are not chemically identical to an analyte of interest.
In this way, IDMS quantification is based on a direct mathematical comparison, not external
calibration. Equation 1 is an example of expressing the concentration that is derived from the
known data and the ratio measurement from the mass spectrometer.44

5

Concentration, μmole/g = [(CsWs/Wx) x iPs-(Ri/n x nPs)] / [(Ri/n x nPx) - iPx] eq. 1
Ri/n = Peak area of isotopically enriched molecule / peak area natural molecule

Where, Cs is the concentration of the isotopically labeled analog of the target anlayte, Ws
and Wx are the masses of the isotopic analog spiked into a sample and the natural sample
(respectively), iPs and iPx represent the fraction of the target analyte in the isotopically enriched
form in the isotopic spike (e.g. 0.99) and the natural sample (e.g. 0.01, respectively), nPs and nPx
represent the fraction of the target analyte present in the naturally occurring form in the isotopic
spike (e.g. 0.01) and natural sample (0.99, respectively).
Being chemically identical and in equilibrium in solution, the endogenous and spiked
isotopes are extracted with equivalent efficiency and recovery. These chemical indistinguishable
isotopically distinct analytes create an advantage of IDMS compared with calibration curve,
internal standards, and response factor quantifications. Once equilibration is achieved between
endogenous and isotopically labeled compounds, IDMS can mathematically correct for many of
the sources of error and variance associated with extraction, mass spectrometry, and
quantification. These sources of error include, among others, imprecise sample preparation, poor
extraction reproducibility, low analyte recovery, instrumental drift, sample loss, and physical or
chemical interferences. Thus, IDMS reduces the contributions of random and analyst errors to
overall quantitative quality, resulting in greater reliability and uniformity of accuracy and
precision. The IDMS quantitative method is described in a standard government method, U.S.
EPA Method 6800, Revision V.44
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1.3.1 Mass Bias Factor
A mass bias factor must be determined experimentally to mathematically correct for the
differences in ionization between the natural and isotopic forms of an analyte in samples at
identical concentrations. A ratio is computed representing the signal intensity of a natural
compound as a function of the signal intensity of the isotopic analog at identical
concentrations.45 This mass bias factor, M.B., is applied as a correction factor to the isotope
signals in the traditional IDMS equation, as given by the following equation:

Concentration, μmole/g = M.B. x [(CsWs/Wx) x iPs-(Ri/n x nPs)] / [(Ri/n x nPx) - iPx] eq. 2
M.B. = ANCi/ AiCN

Where AN and Ai are the signal obtained from the TOF-MS for the natural analyte and
the isotopic analog, respectively. CN and Ci are the concentrations of the natural analyte and
isotopic analog, respectively. Mass bias factors were computed for each compound and used as
an internal correction factor in the quantitative method.

1.4 Solid-Phase Extraction
Solid-phase extraction (SPE) is a sample cleanup and pre-concentration procedure to
isolate analytes of interest from potentially interfering or harmful biological compounds using
primarily hydrophobic interactions and cationic or anionic exchange.46 SPE extracts compounds
from a mobile phase by taking advantage of the selective affinity. Reverse-phase SPE utilizes a
stationary phase (typically in either a column or cartridge form) of linked hydrocarbon packing
to selectively extract hydrophobic compounds from aqueous solutions. Normal-phase SPE uses a
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polar stationary phase to isolate polar compounds from hydrophobic contaminants in a stationary
phase. SPE is often used on aqueous and biological samples to selectively extract and preconcentrate analytes prior to analysis by LC/MS or electrospray ionization (ESI) TOF-MS.
Figure 1.2 demonstrates the procedure for isolating compounds of interest from solution and
contaminating agents in column pass-through scenario.
When applicable, SPE is often used in place of traditional liquid-liquid extraction due to
the increased selectivity afforded by SPE and the reduction in solvent consumption and waste
generation. SPE has been in use since the 1960s and has given rise to newer stationary phases
and extraction procedures.47 Two of the most commonly used SPE technique, in addition to
traditional column and cartridge, are solid-phase microextraction and stir-bar sorptive extraction.

1.4.1 Solid-phase Microextraction
Where column and cartridge SPE extractions rely on so-called “pass-through” extractions
in which a mobile phase is passed through a stationary phase, solid-phase microextraction
(SPME) was one of the first extraction techniques to rely on passive interaction with a stationary
phase.48 This passive interaction could occur via immersion into a solution or suspension into the
headspace of a sample. Traditional SPME uses a flexible metallic fiber coated in a hydrophobic
stationary phase, typically made of polydimethylsiloxane (PDMS). Where SPE reduced solvent
consumption by eliminating liquid-liquid extraction, SPME further reduces solvent consumption
by utilizing a completely thermal desorption procedure. After exposure of a PDMS-coated fiber
to a sample, the adsorbed analytes are then desorbed directly into the carrier gas flow in a heated
inlet of a gas chromatograph (GC). In this way, SPME can eliminate solvent consumption
associated with sample extraction.
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Figure 1.2: Chemical structure of PDMS
The mechanism of SPME extraction is significantly more complex than of traditional
SPE column or cartridge extraction. The following equation represents the amount of an analyte
(nf) present in the stationary phase following SPME extraction:49

nf = cosVfVsKfsK1/(KfsK1Vf + K1Vg +Vs)

eq. 3

Where, Cs is the concentration of the analyte in solution, Vf is the volume of extraction
phase PDMS, Vs is the volume of solution, Kfs is the analyte-specific partition coefficient
between PDMS and aqueous phase (typically approximated by the more-standard Kow), and K1 is
the analyte-specific partition coefficient between gas phase and solution phase. The extraction
mechanism is demonstrated in figure 1.3, showing the passive nature of SPME extraction. Due to
the passive nature, many analytes require up to 24 hours of exposure to a sample to obtain
quantitative extraction.
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Figure 1.3: Passive extraction of an analyte from an aqueous solution using SPME
Due to mechanism limitations of attaching the PDMS stationary phase to a flexible
metallic fiber, the PDMS coating must be attached by epoxy. This means that excessive exposure
of the SPME fiber to an organic solvent will dissolve the epoxy and cause mechanical failure of
the SPME fiber. Because of this, nonvolatile compounds (which cannot be removed thermally)
may irreversibly bind to the SPME fiber and degrade the analytical quality of a fiber. There have
been methods proposed in literature to permit immersive analysis in samples containing
nonvolatile compounds, such as whole blood and blood serum.

1.4.2 Stir-bar Sorptive Extraction
Stir-bar sorptive extraction (SBSE) is a solventless-desorption alternative to traditional
solid phase extraction (SPE)50 that is rapidly gaining application in analytical laboratories. SBSE
utilizes a glass-coated iron core wrapped in a polymeric extraction phase and functions by the
same extraction mechanism as the industry-accepted SPME.48 In addition to a 50 – 100 fold
10

increase in extraction phase volume compared with typical SPME,51 SBSE also changes the
extraction mechanism from a passive diffusion-based adsorption to active sampling by rapidly
stirring an analytical sample.52 Most SPE tools (e.g. cartridges, disks, filters, fibers) are
incompatible with the analysis of biological fluids without significant sample preparation and
cleanup. In contrast with SPME fibers, SBSE bars are not produced with epoxy; rather the
PDMS stationary phase is attached mechanically. This means that SBSE may be conducted in
complex solutions containing nonvolatile compounds that would otherwise cause irreversible
damage to SPME fibers. SBSE bars can be rinsed with small volumes of methanol to remove any
fouling agents to avoid stationary phase damage. Figure 1.4 shows a simple schematic of the
most common type of stir bar used in SBSE.

Figure 1.4: Schematic diagram of a typical stir bar used in SBSE
For the extractions of analytes of mixed-characteristics, dual SBSE has typically been
used as a tandem-in-time extraction.53 For mixed volatility analytes, dual SBSE is conducted by
immersive and headspace analysis simultaneously.54 Following stir-bar extraction, analytes are
thermally desorbed from the bar(s) in the inlet of a gas chromatograph (GC). The relative cost
difference between sorbent stir-bars and other SPE tools means that for SBSE, more than other
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SPE methods, the efficient use of a limited number of stir-bars is often the limiting factor in
overall processing time.
According to the research performed by Baltussen et al., SBSE can theoretically recovery
a quantitative amount of a wider range of analytes, compared with SPME.55 The larger volume
of PDBS present in the SBSE bars should allow for the extraction of greater amounts of typically
poorly extracting compounds (i.e. compounds with a log Ko/w of 4 and lower).
The most common technique for sample analysis using SBSE is thermal desorption into a
gas chromatography / mass spectrometer (GC/MS). Volatilizing the adsorbed analytes from the
stir-bar into the carrier gas stream of the GC/MS eliminates solvent from the desorption process.
As not all compounds will volatilize instantly, a liquid-nitrogen cryo-trap is typically installed
beneath the thermal desorption device.

1.5 Relevance to Research
Technologies have been developed to sensitively extract and accurately quantify tracelevels of environmental pollutants in biological and other aqueous solutions. It was the objective
of this research to combine the relatively simplistic approach of SPE, SPME, and SBSE, with the
high accuracy and precision afforded by IDMS to produce analytical methods that significantly
decreased solvent consumption, provided accurate and precise quantification, and enabled highquality inter-laboratory method transfer for the analysis of biological and environmental samples.
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Chapter 2: Solid-phase microextraction for the analysis of volatile and semi-volatile
compounds in serum

2.1 Introduction
Numerous methods exist to extract and quantify organic pollutants in biological fluids. A
standard, accepted method for the extraction of organic, hydrophobic analytes from aqueous
solutions is by SPME.1, 2 Government standardized methods and regulations have specified the
use of SPME analysis since the 1990s.3,

4

Because of its wide acceptance and broad research

capacity, SPME was chosen as the extraction technique for the development of a method for
analysis of a range of organic pollutants in blood serum.
In clinical analysis, large volumes of sample are often required to attain the analytical
sensitivity to produce actionable quantitative results. Due to the low environmental
concentrations of many organic pollutants, researchers typically quantify these compounds in
milliliter volumes of whole blood or blood serum,5, 6 with 0.5 mL considered an exceptionally
low volume.7 However, for some patients (particularly children and immune compromised) large
volumes of blood are difficult to acquire, especially if taken in conjunction with additional blood
tests. While it is not commonplace for medical practitioners to recommend organic pollutants in
typical blood tests, the general trend toward personalized medicine may one day make this type
of analysis routine.8
Many organic pollutants can be classified as persistent organic pollutants (POPs) based
on characteristics such as low volatility, environmental persistence, and inherent toxicity.9 Many
studies have been conducted to investigate both the acute and chronic health effects of exposure
to many of these POPs.10, 11 These studies were collected and used to develop a list of the most
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commonly researched POPs and their peer-reviewed potential for human health effects. Figure
2.1 demonstrates the structural similarities between these chosen analytes.

Figure 2.1: Structural similarities between selected POPs implicated in human disease states and
etiology
The purpose of this study was to develop an analytical method capable of matching and
exceeding the analytical quality and sensitivity of existing methods for the extraction and
quantification of semi-volatile and volatile POPs in blood serum, while reducing the sample
volume to 200 μL. It was hypothesized that the imprecision and irreproducibility of SPME as the
limit of quantification (LOQ) is approached could be reduced by the addition of IDMS
quantification in place of calibration curves. This developed method would then be further
optimized for immersive analysis of nonvolatile analytes. The developed and optimized method
22

would be validated against certified concentrations of the selected POPs in blank-subtract blood
serum. Once validated, this method would be applied to a collaborative health study
investigating the exposure of ten children with clinician-diagnosed autism to environmental
POPs. Further, this validated method would be used to assess the effectiveness of a sleeping
cleanroom on the ability of these children to detoxify the selected POPs.

2.2 Materials and Methods
2.2.1 Reagents
Benzene, toluene, and o-xylene standards (99.9% pure) were purchased from SigmaAldrich (Saint Louis, MO). Benzene-d6 (99.6% label purity), toluene-d8 (99.6% label purity),
and o-xylene-d10 (99.6% label purity) were purchased from C/D/N Laboratories (Pointe-Claire,
Quebec, Canada). A standard mixture of six unlabeled PCB compounds, IUPAC congeners 28,
52, 101, 138, 153, and 180 (99.8% pure), in isooctane were purchased from Cambridge Isotope
Laboratories (Tewksbury, MA) certified in a NIST-validated laboratory. Solutions of
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C12 -

labeled analogs (99% label purity, 99.8% chemical purity) for each PCB compound in nonane
were purchased from Cambridge Isotope Laboratories.

2.2.2 Instrumental Methods
An automated GERSTEL MultiPurpose Sampler II with thermally controlled agitator and
automated SPME holder, Agilent 7890A Gas Chromatography, and Agilent 5975c single
quadrupole mass spectrometer were used for sample analysis. The SPME fiber used contained a
mixture of PDMS and divinylbenzene (DVB) polymers. A 5%-phenyl polydimethylsiloxane
(PDMS) GC column was used (30m x 0.25mm x 0.25mm) for chromatographic separation
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(Agilent DB-5ms). The quadrupole mass spectrometer was operated in select ion mode, set to the
determined quantitative and confirmatory ions for the VOC and PCB compounds, both
isotopically labeled and unlabeled. Agilent Chemstation and Masshunter were used for data
analysis.
For development, validation, and application, isotopic analogs spikes were added by mass
to all sample replicates and sample vials were vortexed for 5 minutes to ensure equilibration and
homogenation among natural and isotopic molecules. .Samples containing 200 μL of blanksubtracted blood serum and isotopic analog spikes of all analytes of interest were extracted using
SPME for 15 minutes with a a sample agitation of 700 rpm. The automated sampling system
transferred the SPME fiber to the GC inlet to undergo thermal desorption at 300 °C into the
carrier gas stream. Following chromatographic separation, analytes underwent electron
ionization in the mass spectrometry ion source and mass analysis by single quadrupole
spectrometry. For peak identification and integration, the Agilent Agile integration algorithm
was used, with a minimum peak height of 1000 mass spec counts. To assure reproducible
integration results between replicates, the automated Agile integrator was used for all peak area
calculations. Demonstration of peak area automated calculation can be found in figure 2.2. The
Agile integration algorithm recognizes a peak as any point at which the chromatogram baseline
exceeds 1000 units of peak height. The Agile integration algorithm sets the left and right
retention-time bounds as the points at which the peak height falls below 1% of the total peak
height. Then an integration is performed and peak area, in arbitrary units of mass spec counts, is
calculated automatically.
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Figure 2.2: Demonstration of automated peak area calculation by the Agile integrator, bounding
the starting and ending retention times based upon defined limits of peak height
An air-filtration system was installed following method development procedures. The
filtration system consisted of a Plexiglas enclosure surrounding the GC/MS, sample storage
racks, and automated sample-handling robot. The enclosure was sealed at the edges using nonVOC sealant and the exposed aluminum surfaces of the solid frame were sealed using nongassing, non-VOC, and phthalate-free cleanroom paint. Sealed to the top of the enclosure was an
air pump that forced laboratory air through an activated carbon sheet and a high-efficiency
particulate air (HEPA) filter before blowing over the instrumental system. The filter enclosure
system was not sealed at the bottom. In this way, the enclosure was designed to maintain positive
air-pressure and prevent laboratory air from flowing back into the enclosure.
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2.2.3 Analyte Loss Via Septa Puncture
A sealed, spiked serum sample was placed inside of a sealed metal canister with a strip of
activated carbon suspected in the headspace of the metal container. The canister was placed in an
oven at 70 °C for three hours. A second sealed, spiked serum sample was placed into a sealed
metal canister with a strip of activated carbon suspended in the headspace and a SPME fiber was
placed through the septum of the seal vial and remained in the septum throughout the
experiment. This canister was placed in an oven at 70 °C for three hours. Replicates (n=3) were
performed for the sealed sample and the SPME-pierce sample. Analysis was conducted by
placing the activated carbon strip into a vial with 5 mL of hexane and allowed to equilibrate for 1
hour. A 50 μL sample of this extraction phase was directly injected into the GC inlet and a
comparison was generated between the sealed sample vials and the SPME-pierced sample vials.

2.2.4 Method Development and Optimization
For all method development, optimization, and validation experiments, samples
containing 200 μL of blank-subtracted serum were spiked with certified concentrations of an
analyte of interest. Blood serum was brought to room temperature from a -80 °C freezer and
added by mass to a 2 mL GC vial. A stock solution of an analyte of interest at a certified
concentration in a water-miscible solvent was then added to the vial by mass, to achieve a
designated final concentration for the analyte of interest.
Extraction time, extraction temperature, desorption time, desorption temperature, and
cryotrap temperature were optimized experimentally for every analyte, in that order. These
parameters were optimized using solutions prepared using samples containing all analytes of
interest simultaneously. For extraction time optimization, a solution containing 10 μg/g of VOC
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and 10 ng/g of PCB compounds was extracted for 5, 10, 25, and 45 minutes and analyzed using a
validated literature method. The extraction time producing the highest analyte recovery (assessed
as the time-point which produced the largest relative peak area, or the point at which the analyte
recovery plateaued, for the largest number of analytes) was then used to assess extraction
temperature using a similar procedure at temperatures of 23, 35, 50, 70, and 90 °C. The
optimized extraction time and temperature was then used to assess desorption time (5, 15, 25, 45,
and 60 minutes), desorption temperature (150, 200, 250, 275, and 300 °C), and cryotrap
temperature (-150, -100, -50, 0, and 10 °C) in that order.

2.2.5 Method Validation
Samples were prepared by mass containing 200 μL of blank-subtracted serum in 2 mL
GC vials. Certified concentrations of benzene, toluene, o-xylene, and PCBs 28, 52, 101, 138,
153, and 180 were added by mass. Similarly, benzene-d6, toluene-d8, o-xylene-d10, PCBs13C12 28, 52, 138, 153, and 180 were added by mass to attain a final concentration of both
isotopically labeled and unlabeled compounds of approximately 1450 μg/g for the VOC
compounds and approximately 9.12 ng/g for PCB compounds. Samples were analyzed following
the experimentally optimized method parameters found in table 2.1. Following quantification by
IDMS, experimentally determined concentrations were compared at the 95% confidence level to
the calculated certified concentration of the natural (unlabeled) form for each compound.
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Table 2.1: Experimental optimized analytical parameters for the quantification of VOC and PCB
compounds in 200 μL of serum
Parameter

Value

Parameter
Value
CIS
Desorption
300 °C
Temperature

SPME Polymer

PDMS/DVB*

Extraction Time

15 Minutes at
GC Column
70 °C

DB-5ms (30m x 0.25mm x 0.25mm)

SPME
Desorption Time

25 minutes

Flow Rate

1.2 mL/min

Agitation

700 rpm

Oven Ramp

Crytrap
Mass Analysis Mode
-100 °C
*A 1:1 mixture of PDMS and divinylbenzene

40 °C initial, 5 °C/min to 80 °C, 15 °C/min
to 250 °C, 25 °C/min to 300 °C
Select Ion

2.2.6 Statistics
For measurements of accuracy and precision, the percent error from calculated
concentration (%error), percent relative standard deviation (%RSD), and 95% confidence
intervals were used. For validation comparisons, the 95% confidence interval of the
experimentally determined mean was compared with the accompanying ±5% standard deviation
of the certified standard. For comparison of means, p-values were computed to compare the
statistical similarity of two means with unequal variance, with p<0.05 indicating statistically
significant difference. All analyses in blood serum were blank-subtracted using synthetic urine
samples that were not spiked with either the natural or isotopically enriched analytes. Limit of
quantification (LOQ) calculated as the concentration sufficient to present a chromatographic
peak height equal to five-times the chromatographic baseline height.12 Limit of detection was
calculated as the analyte concentration necessary to produce a chromatographic peak height
equal to three-times the chromatographic baseline height.12 Quantification was accomplished
using IDMS quantification.13
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2.2.7 Application to Clinical Research: Autism Cleanroom Study
After obtaining approval from the Institutional Review Board (IRB) of Duquesne
University (Pittsburgh, PA, USA, IRB #09-131), the cleanroom was created and the study was
conducted at The Children’s Institute (TCI, Pittsburgh, PA, USA). Before enrolling in the study,
consent was obtained, and a pictorial document explaining the study was reviewed with each
child.

2.2.7.1 Subject Enrollment and Study Design
Ten children, ages 3-12, with autistic disorder confirmed by a psychologist who is
research certified to perform the Autism Diagnostic Observation Schedule (ADOS)

14

were

recruited from the Neurodevelopmental Service of TCI. Eligible children were required to
present low plasma zinc/serum copper ratios and abnormal T and B cell subsets. Child #2 was
unable to participate in the study because of the inability to complete a blood draw. The group
intentionally contained two sets of identical twins (ages 5 and 12). Children were not eligible if
they had severe behavioral dysregulation, uncontrolled seizure activity, or any other severe
chronic medical condition, other than autism, that required frequent management by
pediatricians.
After signing the consent and being provided opportunity for child assent, each child and
a parent spent two consecutive weeks for a minimum total of ten contiguous hours each night in
the cleanroom between May and October 2010. During the day, the child and parent went about
their normal activities and therapies. A research assistant recorded each child’s sleep behaviors.
The children and family’s adjustment to the study was monitored by a Family Advocate
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Psychologist who had no academic involvement in the study. Diet, medications, nutrients, and
experiential services were held constant throughout the study.

2.2.7.2 Blood Draws and Clinical Testing
Within 24 hours before and after the two-week period of sleeping in the cleanroom,
approximately 30 mL of blood was drawn at the child’s home by a phlebotomist specializing in
children with developmental disabilities. The blood was separated by centrifuge and aliquoted
for storage at -80 °C. The Duquesne University testing included elemental analyses in serum,
plasma, RBCs, and hair; total, oxidized, and reduced glutathione in RBCs; and benzene, toluene,
and o-xylene along with selected polychlorinated biphenyls (PCBs) in serum. Greater detail on
blood collection, processing, and storing for this work has been previously described
elsewhere.15, 16

2.2.7.3 VOC and PCB Quantitative Methods
IDMS quantification was performed on the volatile organic compounds (VOCs) benzene,
toluene, and o-xylene using methods and procedures outlined in EPA Method 16243 and selected
PCBs (PCB-28, PCB-52, PCB-101, PCB-138, PCB-153, and PCB-180) using the modified
methods and procedures outlined in EPA Method 1625 and recent peer-reviewed studies.4, 17, 18
Separate analyses were completed for VOC and PCB quantification, each requiring 200 µL of
serum spiked with 2H labeled versions of each VOC or 13C labeled versions of each PCB. SPME
was performed on the headspace of the samples using a PDMS/DVB fiber. Replicates were
performed (n=3) for each sample, both before and after the cleanroom.
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2.3 Results and Discussion
Method development, optimization, and validation were performed using 200 μL of
blank-subtracted serum spiked with certified standards of the analytes of interest.

2.3.1 Assessment of Analyte Loss
To obtain accuracy and maintain maximum sensitivity, volatile analyte loss over time
was investigated in blank-subtracted serum spiked with 10 μg/g benzene, then frozen in a -80 °C
freezer to simulate storage of blood serum samples. The change in peak area over storage-time
was determined in two sets of six samples spiked: one set brought from 0 °C to 23 °C and stored
until the appropriate analysis time, and one set brought from 0 °C to 2 °C and held at that
temperature until the appropriate analysis time. Figure 2.3 shows the change in peak area over
time of these two sets of samples. After 15 hours out of the -80 °C freezer, both sets of samples
lost peak area, with the set stored at 2 °C decreasing by 25% and the set stored at 23 °C
decreasing by 44%. This represents a maximum observed improvement in sample stability of
175% by storing spiked blood serum at 2 °C prior to analysis of benzene.
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Figure 2.3: The change in peak area of two sets of serum samples spiked with 10 μg/g benzene:
one stored at 23 °C and one stored at 2 °C.
Benzene was chosen as an appropriate analog, as it has the highest vapor pressure of the
studied analytes. Sealed samples of spiked serum permitted loss of 10-times more benzene when
heated in an oven at 70 °C with a SPME needle piercing the septum compared with sealed
samples without a SPME needle in the septum. These results suggest that, while stored in the
sample tray, compounds may have volatilized into the vial headspace where they leaked when
the septum was pierced by the SPME needle. While IDMS quantification corrects for imprecise
extraction efficiencies and sample loss, a chilled sample-tray was used to keep all serum samples
at 2 °C throughout the duration of the automated sample analysis sequence to minimize VOC
volatilization and subsequent analyte loss. Once spiked and equilibrated with the isotopic labeled
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analogs, analyte loss affects sensitivity but does not affect accuracy, as the isotopic analog is
lossed at identical ratios.

2.3.2 Assessment of Immersive SPME
A significant component to method development in this work focused on developing a
process to allow immersive SPME in complex, confounding sample solutions: such as blood
serum. Peer-reviewed sources provided various methods for the treatment of blood serum to
permit immersive extraction without damage to either the SPME fiber or analytical
instrumentation.19

20, 21

Following literature methods, blood serum samples were treated with a

broad-spectrum serine protease, proteinase K, to digest proteins present in the serum by cleaving
at hydrophobic amino acids. Literature had reported a significant increase in sample-to-sample
reproducibility using this method. However, this laboratory was not able to reproduce these
results. Treatment with proteinase K was found to not prevent SPME fiber fouling upon
immersion into protein and lipid-containing samples.
While the original research that recommended proteinase K suggested that this treatment
could prevent fouling,19 it is likely that the instrumentation in use by Poon et al. contributed to
these incorrect conclusions. The SPME fiber used by Poon et al. was not designed to retract into
a metallic sheath, a very common SPME configuration today. Because of this, the primary
fouling-related problem encountered by Poon et al. was a reduction in sample-to-sample
reproducibility. However, modern laboratories using SPME mechanisms with retractable PDMS
fibers encounter a separate problem: as proteins and lipids build up on the PDMS fiber, the
irreversibly bound agents coating the fiber can “catch” on the metallic sheath and remove or strip
the PDMS coating from the metallic fiber. Therefore, this laboratory was unable to reproduce or
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confirm the conclusions made by Poon et al. that proteinase K can increase sample-to-sample
reproducibility, these results have confirmed that this treatment does not prevent SPME fiber
fouling or allow for immersive SPME analysis. This laboratory found that the SPME retractable
fiber was only useful for 2 to 4 uses before physical failure destroyed the SPMS after immersion
in serum.

2.3.3 Analytical Parameter Optimization
Extraction time, extraction temperature, desorption time, desorption temperature, and
cryotrap temperature were optimized experimentally, in that order of priority, to achieve the
greatest analyte sensitivity. Figure 2.4 demonstrates the optimization of a mixture of PCB
congeners in blank-subtracted serum spiked with 10 ng/g of each PCB. Extraction efficiency
plateaued for all PCB compounds after 10 minutes of extraction. The VOC analytes were
optimized similarly. Experimentally optimized analytical parameters can be found in table 2.1.
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Figure 2.4: The experimental optimization of extraction time for blank-subtracted serum samples
spiked with 10 ng/g of seven PCB congeners
2.3.4 Method Validation
Quantification of VOC and PCB compounds was performed by IDMS, which was found
to correct for much of the analytical imprecision. Analytes of interest were identified in the
chromatogram using the quantitative and confirmatory peaks found in table 2.2. Isotopically
labeled analytes were positively identified using the quantitative ion and retention time of the
naturally occurring analog.
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Table 2.2: Ions (m/z) for identification and quantification for the labeled and unlabeled analytes
of interest
Analyte
Benzene
Toluene
o-Xylene
PCB-28
PCB-52
PCB-101
PCB-138
PCB-153
PCB-180

Natural Molecule
Quantitative Ion
78
91
106
186
220
291
290
256
360

Confirmatory Ion
51
65
91
256
292
326
360
326
394

Isotopically Labeled Molecule
Quantitative Ion
Confirmatory Ion
84
98
116
198
232
303
302
268
372
-

Figure 2.5 (top) shows a calibration curve generated for PCB-52 spiked into 200 μL of
blank-subtracted blood serum at varying concentrations (n=3). This calibration curve yielded
poor mean precision (16.2 %RSD) and linearity (R2=0.97642). Figure 2.5 (bottom) shows the
same data, with each axis adjusted to represent the ratio between naturally occurring and
isotopically labeled values. With this adjustment, significant improvements were observed in
both mean precision (5.12 %RSD) and linearity (R2=0.99996).
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Figure 2.5: a: (top) Calibration curve generated for PCB-52 spiked into 200 μL of blanksubtracted serum at varying concentrations, and b: (bottom) the same data corrected using IDMS
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Validation was performed by comparing experimentally determined concentrations with
certified concentration in 200 μL of blank-subtracted serum samples using the optimized SPMEGC-IDMS method parameters. Mean quantitative accuracy exhibited 9.29% error with a mean
precision of 12.1 %RSD. Limit of quantification was calculated to be 6.50 ng/g for all VOC
compounds and 0.250 ng/g for all PCB compounds. The three order of magnitude difference in
LOQ between the PCB and VOC compounds can be attributed, in part, to significantly higher
background noise generated in the blanks at the retention times associated with benzene, toluene,
and o-xylene. Validation results for each analyte of interest are summarized in table 2.3. Figures
2.6 (top) and 2.6 (bottom) demonstrate visually the overlap between the experimental and
certified concentration values.

Table 2.3: Validation results for the analysis of VOCs and PCBs in 200 μL of spiked serum
Analyte
Benzene
Toluene
o-Xylene
PCB-28
PCB-52
PCB-101
PCB-138
PCB-153
PCB-180

Certified Values (ng/g)
Concentration
95% CI
14.5
0.73
14.5
0.73
14.5
0.73
9.12
0.46
9.12
0.46
9.12
0.46
9.12
0.46
9.12
0.46
9.12
0.46

Experimental Values (ng/g)
Concentration
95% CI
15.5
2.5
15.7
1.7
14.1
0.32
10.4
1.9
9.49
0.49
10.2
1.2
8.28
1.3
10.3
3.0
10.4
1.0
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|%Error|
6.92
8.51
2.63
13.9
4.06
11.8
9.21
12.4
14.1

%RSD
16
11
2.3
18
5.2
12
16
20
9.7

LOQ (ng/g)
150.
150.
150.
0.250
0.250
0.250
0.250
0.250
0.250

Figure 2.6: A comparison between the experimentally determined concentrations of all target
analytes to be used in a collaborative clinical study with certified standards spiked into blanksubtracted serum for (top) PCB and (bottom) VOC compounds. Bars show 95% confidence of
experimentally determined values and shaded area represents 95% confidence interval of
certified standard.
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The trace-level quantification of this research demanded the elimination of all potential
background contamination to produce high-quality quantitative data. Sample analysis and
lengthy automated sample sequence times may have allowed laboratory-air to contaminate the
analytical process by a number of contaminant introduction routes: adsorption of volatile
compounds from the laboratory air onto the SPME fiber as it sat unused, introduction of
laboratory air into the GC system upon SPME injection into the inlet, or through an unknown
introduction route. Background contamination was successfully reduced to levels below the limit
of detection of the instrumental system by installation of a filter system containing activated
carbon and a HEPA filter.

Figure 2.7 demonstrates the improvement in background

contamination that was observed when the enclosure was added to the GC/MS system. For
determination of the effectiveness of the filter system, a high electron multiplier amplification
was used, gain-factor of 9.0 (equivalent to an electron multiplier voltage of 2400 eV.)
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Figure 2.7: (left) Extracted ion chromatogram of the three most abundant contaminant peaks
observed with a high electron multiplier amplification, and (right) the same extracted ion
chromatogram showing baseline at the retention times associated with the contaminants
*Chromatographic peak extends above the limit of the y-axis

2.4 Application to Cleanroom Research and Autism Spectrum Disorders: A Pilot Study
2.4.1 Introduction to Clinical Study
Many researchers believe that the increase in autism diagnoses can be, at least in part,
attributed to exposure to environmental pollutants.22-24 While genetic factors clearly play a role
in the development and maintenance of autism disorders,25,

26

studies have provided indirect

evidence to correlate autism diagnosis with exposure to a variety of environmental triggers like
organophosphate pesticides,27 as well as maternal exposure to traffic-related air pollution,28 and
thalidomide.29 Further research is required to investigate, not only correlative relationship, but
potential mechanistic relationships that may exist between environmental triggers and the
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development of ASDs.30 While there is no universal agreement on which, if any, environmental
triggers play a role in the development and maintenance of autism disorders, nearly unanimous
agreement exists among medical researchers that no evidence, direct or indirect, exists to
correlate or link autism diagnosis with vaccinations.31-34
Multiple studies have demonstrated the importance of early treatment interventions in
individuals with ASDs. 35-37 It has been shown that younger children with autism display greater
and more rapid response to intensive treatments, and that there may be a crucial time interval for
intervention before the end of early life developmental plasticity. 35 It was therefore hypothesized
in a collaborative pilot study with The Children’s Institute of Pittsburgh that an intervention that
temporarily decreases environmental exposure to an individual, by isolation in a cleanroom
environment, may reduce the presentation of autism symptoms. Results of this work could allow
researchers to evaluate the feasibility and potential effectiveness of a full-scale study.

2.4.2 VOC and PCB Mean Quantitative Results
Comparing mean concentrations of each analyte across the ten participants before a
cleanroom intervention to mean concentrations after yielded no statistically significant change.
Table 2.4 demonstrates that all participants displayed quantifiable concentrations of benzene,
toluene, o-xylene, and PCB-101. Before and after concentration changes for toluene and PCB-28
demonstrated the highest statistical significance (p=0.0769 and p=0.0829, respectively), but did
not meet the cut-off of p<0.05. Mean quantitative results for all analytes pooled across the entire
study before and after cleanroom intervention can be found in table 2.4. Low precision obtained
in the quantification of VOC and PCB compounds was a significant limitation in statistical
comparison of pre- and post-cleanroom mean concentrations.
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Table 2.4: Mean concentration (ng/g serum) of all studied analytes in all ten children both before
and after the cleanroom, showing 95% confidence and the significance of before/after difference
Analyte
Benzene
Toluene
o-Xylene
PCB-28
PCB-52
PCB-101
PCB-138

Before Cleanroom
Concentration 95% CI
9.49
3.8
0.747
0.20
0.8259
0.12
0.519
0.16
0.688
0.22
6.18
2.1
0.695
0.20

n
10
10
10
6
8
10
6

After Cleanroom
Concentration 95% CI
7.52
3.6
0.950
0.27
0.867
0.19
0.721
0.21
0.613
0.18
7.23
2.3
0.661
0.14

n
10
10
10
7
8
10
6

p-value*
0.253
0.0769
0.56
0.0829
0.469
0.305
0.737

*P-value comparison between mean concentration of each analyte before and after cleanroom
n: Number of children displaying quantifiable concentrations of specified analyte

2.4.3 Age-Dependent Detoxification Trends
Analysis of mean concentrations found that the change in serum benzene concentration
negatively correlated with age with high statistical significance and high negative correlation
(p=0.021, r= − 0.71). There were no significant differences in VOC concentrations in paired ttests of pre- and post-cleanroom findings for the set of ten children. However, this calculation
did not account for the high imprecision present in the quantification of benzene.
Analysis of mean concentrations found that the change in serum PCB-28 negatively
correlated with age with high statistical significance and high negative correlation (p=0.028, r= −
0.72), as seen in figure 2.8. PCBs 52, 101, and 138 were not found to have undergone significant
changes in concentration between pre- and post-cleanroom measurements. PCBs 31, 153, and
180 were not quantifiable in any of the ten children. There were no significant differences in
PCB concentrations in paired t-tests of pre- and post- findings for the entire cohort. However, as
with benzene, the high degree of uncertainty present in the quantification of PCB-28 eliminates
the drawing of conclusive, medically relevant results.
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Figure 2.8: Figure 2.4: The change in PCB-28 serum-concentrations between pre-cleanroom and
post-cleanroom measurement, arranged by age of child. Dashed line represents no change.
p=0.028, r= − 0.72
The increase in the means of benzene and PCB-28 serum-concentrations after the
cleanroom in the younger children correlated with an improvement on the autism rating scales
and observations.16 However, due to confounding variables, such as the pilot-nature of this study,
lack of a control cohort, and high degrees of uncertainty present in quantitative results, the
observed neurological improvements could not be unequivocally attributed to an improvement in
autism severity. The results of this study indicate that a full-scale investigation of the effects of a
cleanroom environment on the severity of autism symptoms in children with ASDs and
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neurotypical controls is a reasonable next step. Future research in full-scale implementation
should include a controlled cohort-study with a increased sample size using a 24 hour per day
cleanroom with control over participant diet. Additionally, improved analytical methods must be
developed to increase quantitative quality and decrease uncertainty.

2.5 Conclusions and Preliminary Findings
A method for the analysis of VOC and PCB compounds in microliter volumes of human
serum was modified from literature sources by the addition of IDMS quantification. The method
was optimized for the specific analytes of interest and validated against matrix-matched certified
standards. This method was the first to specifically correct for the irreproducible nature of SPME
by the addition of true IDMS quantification. The optimized and validated method demonstrated
high accuracy and precision, as well as a sensitivity to be useful for environmentally relevant
quantification.
The validated analytical method was applied to a collaborative pilot study assessing the
effect of a cleanroom sleeping environment on the xenobiotic body-burden of children with
autism. The developed and optimized method provided high analytical quality in method
development and validation using blank-subtracted blood serum spiked with analytes of interest
under strictly controlled sample preparation parameters. Greater control must be gained over the
entire sample analysis process to ensure that highly precise data are obtained from real clinical
samples. While the feasibility of such a study was demonstrated, improved analytical methods
must be developed prior to implementation of full-scale research.16
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Chapter 3: Simultaneous extraction of volatile, semi-volatile, and non-volatile compounds
from environmental waters and biological samples

3.1 Introduction
The rapidly developing environmental human health field of exposomics requires
specialized and optimized analytical methods to be accurately and reliably deployed academic,
government, clinical, environmental, and commercial laboratories. As the emergent field
advances, study of the human health impact of environmental pollutants has increasingly focused
on chronic exposure to POPs (e.g. long-term ingestion and inhalation from environmental and
industrial sources). Thus, regional and demographic data concerning human exposure to specific
pollutants has become increasingly important to medical and academic researchers.1
Compound selection for this method development work was based upon previous
research implicating specific compounds and chemical classes relevant for exposomic and
environmental human health research. The compounds chosen for this development work can be
found in table 3.1.

Table 3.1: Compound list for method development experiments
Benzene
PCB-28
Toluene
PCB-52
o-Xylene
PCB-101
Chlorpyrifos
PCB-138
Pendimethalin
PCB-153
Metolachlor
PBDE-47
Acetochlor
PBDE-99
DEHP
Additionally, compounds chosen for method development represented a significant range
of volatility and hydrophobicity (measured as the octanol/water partition coefficient, Ko/w).
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Figure 3.1a and figure 3.1b demonstrate the several orders of magnitude of volatility (kPa) and
hydrophobicity (Ko/w) of the target compounds used this this research. The purpose of including
such varied compounds was to demonstrate the potential applicability of a developed method to a
significantly wide range of future analytes of interest- enabling future expansion of a developed
method to additional compounds of interest that may fall within the demonstrated range of
chemical characteristics.
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Figure 3.1: Demonstration of the wide range of compounds encapsulated in this method
development work, showing hydrophobicity (top) and volatility (bottom).
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3.2 Background
The assessment of the interaction between the environment and human genetics and
epigenetics is called exposomic research. This section describes a method that was developed for
the extraction and quantification of select POPs in human serum, to build upon the SPME
method described in Chapter 2. This developed method was then applied to assessed in an
equally complex matrix: drinking water and wastewater analysis, with the purpose of updating
outdated standard Methods.
As described in Chapter 2, SPME proved to be useful for only headspace analysis,
contrary to published researched. Thus a new method that accomplished all major POPs
categories volatile, semi-volatile and non-volatile had to be developed. This chapter discusses
this development and the attributes that permitted the RBC to be accomplished as later discussed.
It has been shown that desorption of analytes from the stir bar sorbent phase prior to
analyte-extraction phase equilibrium yields non-reproducible results.2 However, driving these
extractions to equilibrium often requires prohibitively long extraction times; studies have shown
that up to 14 hours is often required for complete equilibration of POPs compounds between the
extraction phase (PDMS) and the solution.3, 4 Citing equilibration time constraints, studies have
indicated the need to develop techniques to ensure pre-equilibrium sample-to-sample
reproducibility in SBSE.5 A direct mathematic quantification eliminates inaccuracy introduced
by relative quantification methods like calibration curve and response-factor (RF) correction.6
Accurate quantification is accomplished by isotope dilution mass spectrometry, as described by
EPA Method 6800.7 EPA and peer reviewed methods using isotope dilution quantification for
POPs require the analyst to generate calibration curves based upon relative isotopic RFs. All
forms of calibration are relative by nature. True isotope dilution is a direct quantification that
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avoids the relative nature of external calibration curves or RFs. This type of quantification is
called isotope dilution mass spectrometry (IDMS).
Environmental sources of human exposure to POPs can include air, foods, manufacturertreated products in the home, and municipal water supply, among many others. The analysis of
differing contaminated matrices have historically required varying analytical procedures for
extraction and quantification of POPs. Water, specifically drinking water and wastewater, are
carefully regulated by the US EPA and the Clean Water Act (CWA). The EPA has produced
standard methods for the analysis of a variety of POPs in multiple aqueous matrices. In total, 18
EPA methods have been produced by the standards outlined in the CWA to govern the
quantification and/or identification of organic pollutants in aqueous matrices for public health.
The most comprehensive of these methods is EPA Method 625, which specifically outlines a
procedure for the quantification of 47 POPs from municipal water and industrial wastewater.
Developed in the early 1980s, Method 625 requires liquid-liquid extraction as a means of sample
preparation and isolation. This type of extraction uses large volumes of toxic solvents to extract
hydrophobic compounds from aqueous solutions. In the 1990s, a separate EPA Method was
developed, Method 525.2, for the analysis of a similar suite of POPs in drinking water. Method
525.2 improved upon Method 625 by incorporating the use of solid-phase extraction techniques
to eliminate liquid-liquid extractions.
One of the primary objectives of this research was to increase efficiency and reduce
variance in sample preparation, while simultaneously improving quantitative accuracy without
using external calibration curves or isotopic RFs. To increase efficiency, this research optimized
single stir-bar SBSE to extract both volatile and nonvolatile analytes from a sample in a single
extraction. To improve SBSE reproducibility and accuracy, IDMS was applied to reduce the
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influence of pre-extraction equilibrium analysis and imprecise sample preparation on quantitative
quality. For the purpose of clinical application, sample volume was optimized to significantly
reduce the volume required compared with existing methods. Another objective of this work was
to validate SBSE for use with EPA Method 625 as an improved sample preparation technique.
Application of the developed method to both clinical and environmental samples was validated
using certified standards. The transferability of the automated method was assessed using an
independent laboratory and separate analyst.

3.3 Materials and Methods
3.3.1 Reagents and Materials
For quantification in blood serum, the following standards were acquired: a standard
containing 7 polychlorobiphenyl (PCB) congeners [2,4,4’-PCB (PCB-28), 2,2’,5,5’-PCB (PCB52), 2,2’,4,5,5’-PCB (PCB-101), 2,2’,3,4,4’,5-PCB (PCB-138), 2,2’,4,4’,5,5’-PCB (PCB-153),
2,2’,3,4,4’,5,5’-PCB (PCB-180), and 2,2’,3,3’,4,4’,5,5’-PCB (PCB-209)] and standards for
polybrominated diphenyl ether (PBDE) congeners [2,2’,4,4’-BDE (PBDE-47) and 2,2’,4,4’,5BDE (PBDE-99)] were purchased from Sigma-Aldrich (St. Louis, MO). Benzene, toluene, oxylene, (≥99% purity) and bis(2-ethylhexyl) phthalate (DEHP) were purchased from Fluka (St.
Louis, MO). Certified standards for chlorpyrifos (99.5% pure), pendimethalin (98.8% pure),
acetochlor (98% pure), metolachlor (98.6% pure), toluene-d8, o-xylene-d10 were obtained from
SPEX CertiPrep Group (Metuchen, NJ). A certified standard for benzene-d6 was obtained from
Cerilliant (Reston, VA). Chlorpyrifos-d10 (99% labeled), a standard mixture of PCB-13C12 (99%
labeled, and standards for PBDE-47 and 99-13C12 (99% labeled) were obtained from Cambridge
Isotope Laboratories, Incorporated. (Tewksbury, MA). Pendimethalin-d5 (98% labeled),
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acetochlor-d11 (98% labeled), metolachlor-d6 (98% labeled), and bis(2-ethylhexyl) phthalate-d38
(DEHP-d38) were obtained from C/D/N Isotopes Incorporated. (Pointe-Claire, Quebec, Canada).
For quantification of POPs in drinking and waste waters, the following standards were
acquired: a mixture of a mixture of 4-bromophenyl phenyl ether-d5, 2-chloronaphthalene-d7, 4chlorophenyl phenyl ether-d5, di-n-butyl phthalate-d4, diethyl phthalate-d4, di-n-octyl phthalated4, hexachlorobenzene-13C6, hexachloroethane-13C, isophorone-d3, trichlorobenzene-d3, at 98%
label purity and 99% chemical purity at 5000 µg/mL; a mixture of acenaphthene-d10, anthracened10,

benzo[k]fluoranthene-d12,

bis(2-chloroethyl)

ether-d8,

chrysene-d12,

fluorene-d10,

naphthalene-d8, pyrene-d10, at 98% label purity and 99% chemical purity at 2500 µg/mL; and
0.01g of β-BHC-13C6, 4,4’-DDT-d4, and 4,4’-DDD-d4. Unlabeled analogs of each POP were
acquired at 99% chemical purity for method development, optimization, and validation.
Extractions were carried out using 10 mm x 0.5 mm (length x film thickness) polydimethyl
siloxane (PDMS) stir-bars, supplied by GERSTEL (Mülheim a/d Ruhr, Germany) in 10 mL
headspace vials for extractions (Sigma-Aldrich). Stirring was conducted using a 20-position
magnetic stir-plate (GERSTEL). A SPME assembly was purchased with a PDMS fiber of 30 m
film thickness (Sigma-Aldrich) for method comparison studies. Prior to use, the stir-bars were
conditioned per manufacturer instructions. Thermal conditioning took place in a thermal
conditioning unit (TCU) at 290 C for 4 hours with a helium flow of 50 mL/min. HPLC-grade
methanol (Sigma-Aldrich) and ultrapure (18 ) water were used for reagent dilution, glassware
cleaning, and stir-bar cleaning.
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3.2.2 Analyte Selection
For development and optimization, previous studies guided the choices of the most
representative analytes to encompass the many classes of chemical activity defined as POPs. For
biological analysis, traditional POPs classes were included (PCB, PBDE), along with compounds
that have not traditionally been classified as POPs but display the characteristics of semivolatility, environmental persistence, and hydrophobicity.8 Many of the analytes chosen for this
research are not present on the Stockholm Convention list of POPs; this work was designed to
include both banned POPs and products with similar chemical characteristics which have
become environmentally ubiquitous.9, 10 Selected compounds ranged several orders of magnitude
in hydrophobicity (octanol:water partitioning coefficient, Ko/w) and volatility (torr). Three
volatile organic compounds (benzene, toluene, and o-xylene), five PCBs (standard congeners 28,
52, 101, 138, and 153), two PBDEs (standard congeners 47 and 99), two organochlorine
pesticides (metolachlor and acetochlor), one dinitroanaline pesticide (pendimethalin), one
organophosphate pesticide (chlorpyrifos), and one phthalate (bis(2-ethylhexyl) phthalate) were
chosen for this research.
For drinking water and wastewater, an additional 19 compounds were chosen from the
list of base-neutral compounds listed in EPA Method 625, representing a several order of
magnitude range of Ko/w and volatility. The complete compound list found in EPA Method 625
was reduced to 19 to include the complete breadth of volatility and hydrophobicity found in
Method 625, while eliminating compounds of similar chemical characteristics.
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3.3.3 Sample Processing
For preparation of blood serum: in an International Standards Organization Class 5
cleanroom, whole blood samples obtained in an internal review board-approved collaboration
with The Children’s Institute of Pittsburgh (Pittsburgh, PA) were separated into red blood cells
and serum using a calibrated centrifuge. Both serum and red blood cells were immediately
transferred to airtight polyethylene containers and stored in the dark at -80 °C.
For preparation of industrial wastewater: synthetic wastewater samples were prepared
according to ASTM-D5905 procedures. Stock wastewater was divided into two solutions:
synthetic wastewater and synthetic wastewater modified with 20% acetonitrile.

3.3.4 Stir-bar Extractions
For development and validation work on blood serum, samples were brought to room
temperature and approximately 200 L was added by mass to a 10 mL extraction vial using an
analytical balance. A mixture of enriched isotopic analogs was prepared by mass at a
concentration equal to the certified concentration of the target analyte and spiked by mass into
each sample vial. For this study, 100 L of a mixture composed of ~25 g/g benzene, toluene, oxylene; ~4 g/g PCB-28, PCB-52, PCB-101, PCB-138, PCB-153; ~5 g/g PBDE-47, PBDE-99,
chlorpyrifos, metolachlor, acetochlor, pendimethalin, and DEHP was accurately spiked into each
vial of serum.
For work on drinking water and wastewater, 9.5 mL of stock wastewater (either
unmodified or acetonitrile modified) were added to a 10 mL sample vial. A mixture of enriched
isotopic analogs of each EPA 625 analyte to give a final approximate concentration of 100 ng/g
of each enriched compound. All blanks and samples were prepared following EPA Method 625
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and the internal document “ITN-261: Standard and Sample Preparation for EPA 625 Study,”
where it amended EPA Method 625. This method was modified for use with IDMS in minor, but
significant, ways. A second analyte mixture was prepared that contained an isotopically massupshifted labeled analog for each analyte included in this study. The isotopic analogs in the
mixture were at accurately known concentrations, such that each labeled molecule could be
spiked into a wastewater sample within one order of magnitude in concentration of its unlabeled
counterpart.
Following the standard method, each sample replicate was analyzed with two stir bars:
one extracting from an unmodified solution and one extracting from a 20% acetonitrile solution.
Each sub-sample and blank was prepared following the standard method; however, prior to stir
bar extraction, 1.6 mL of the mixture of labeled analytes was spiked by mass into each subsample vial. Labeled-unlabeled equilibration occurred during the stir-bar extraction process,
which was conducted for 60 minutes.
For dual SBSE, one bar was added to the vial with 2 mL of ultra-pure water and one bar
was hung in the headspace on a metallic wire with string. For S-SBSE, one stir-bar was
immersed in the solution and ultra-pure water was added such that the extraction vial was
completely filled to eliminate as much headspace as possible. For blood serum, methanol was
added, before extraction, to each sample to achieve a final methanol concentration of 20%
(including the methanol from the isotope mixture) after dilution. For water samples, no solvent
was added during sample preparation- as acetonitrile was added in the stock dilution step.
Teflon-lined screw caps were fixed to the extraction vessels. Extraction was conducted at 1500
rpm for 60 minutes. The stir-bars were removed from the sample with tweezers and thoroughly
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rinsed with ultrapure water and dried with a lint-free tissue and deposited into a glass thermal
desorption tube. Dual SBSE and single SBSE are compared graphically in figure 3.2.

Figure 3.2: Schematic of a two stir-bar extraction method in which volatile and semi-volatile
compounds are extracted (a) from the headspace on one stir-bar and the nonvolatile compounds
on a second immersed stir-bar or (b) simultaneously with the nonvolatile compounds on one stirbar immersed in the diluted solution.
3.3.5 Desorption and Chromatography
Desorption tubes were loaded into a tray and introduced sequentially into the thermal
desorption unit (TDU) (GERSTEL). The GC inlet was set to use programmed-temperature
vaporization (PTV) on a chilled injector system (CIS-6) (GERSTEL) inlet containing a CIS/TDU
inlet liner packed with Tenax TATM (Buchem B.V., Apeldoorn, The Netherlands). The CIS-6
injector was installed in an Agilent 6890 GC - 5975 MS system (Agilent Technologies, Santa
Clara, CA, USA). The sample loading and handling was performed by a dual-head robotic
multipurpose sampling system (MPS-2) (GERSTEL). The method parameters were programmed
to the final desorption temperature of 280 ºC and the analytes were desorbed under helium in the
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TDU before cryofocusing at -70 ºC in the PTV system with liquid nitrogen. Finally, the CIS
system was ballistically heated at 720 ºC/minute to 280 ºC to transfer the analytes to the GC-MS
for analysis. The analytes were separated chromatographically using an HP-5 MS column (30
mx0.25 mm I.D. 0.25 m film thickness, 5%-phenyl polydimethylsiloxane) at a 1.0 mL/minute
carrier gas flow rate. The GC oven was heated from 45 ºC to 280 ºC at 12 ºC per minute, where
it was held for 15 minutes. Ionization was conducted in electron ionization mode and mass
selection / detection was accomplished in select ion mode (SIM) programmed to the quantitative
and secondary ions selected for each analyte in the method development stage.

3.3.6 Inter-Laboratory Analytical Method Transfer
Unenriched versions of one organochlorine pesticide, one dinitroanaline pesticide, one
tetra-substituted PCB, two co-eluting hexa-substituted PCBs, and one PBDE were spiked into a
mixture of ultrapure water. Five replicates were processed at an off-site, independent laboratory
by an analyst that received minimal training (i.e. two hours) on the extraction, analysis, and
quantification steps. Accompanying the reagents and supplies were electronic versions of the
analytical protocol, instrumental and data processing methods, and an automated internally
developed quantification software. Samples were processed by the independent analyst and final
quantitative values were generated automatically and sent back to the primary laboratory for
comparison.
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3.4 Blood Serum Results and Discussion
A method was developed, optimized, validated, and explored for clinical application
using blood serum and organic environmental pollutants related to human-health measurements.
This section will describe the results of these experiments as they relate to analysis of blood
serum only. The analytical method was optimized to produce a resolved chromatographic spectra
containing all analytes of interest. Figure 3.3 demonstrates the fully resolved chromatogram
containing all analytes of interest.

Figure 3.3: Resolved chromatogram generated using the optimized method developed in this
work, showing all analytes of interest
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3.4.1 Single vs. Dual Stir-Bar Extraction
Single and dual bar extraction recoveries were compared by replicate extractions of a
prepared mixture of endogenous NIST-traceable standards by each method. Total analyte
recovery with single bar SBSE was comparable with dual bar SBSE, producing statistically
identical recovery for 13 out of 15 analytes. As figure 3.4 demonstrates, the highest volatility
analytes, benzene and toluene, presented recoveries 85% and 45% lower, respectively, in single
step extraction compared with dual SBSE. Other POPs typically extracted using headspace
methods: PCBs, PBDEs, phthalates, and pesticides displayed statistically identical recoveries
using the single step analysis.

Figure 3.4: A comparison of relative recovery between single and dual stir bar extraction,
showing 95% CI (n=5)
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Single bar SBSE increased method efficiency and allowed twice as many samples to be
extracted simultaneously, while producing recoveries comparable to dual SBSE. Sorbent stir bars
possess an inherent lifespan. Manufacturer recommendations list this lifespan at 50-extractions;
however, internal research determined that under light use (moderate pH and primarily aqueous
samples), nearly 100 extraction could be performed before extraction efficiency fell below
acceptable levels. The increasing popularity of SBSE stir bars, combined with their relatively
high cost, demands that laboratories make the most efficient use of the available number of bars.
The improved efficiency afforded by extracting with one stir bar instead of two would most
obviously benefit laboratories that process large numbers of mixed-volatility samples.

3.4.2 Sample-to-Sample Reproducibility
Replicates of a prepared mixture of NIST-traceable endogenous standards were extracted
from blood serum by single bar SBSE to determine sample-to-sample reproducibility. Prior to
quantification, analysis was performed on the reagent serum to determine the concentration of
any existing background contamination present in the serum. These background values were
subtracted from any data obtained from the reagent serum, producing a so-called “blanksubtracted serum.” Standards were added to the serum using an analytical balance, to enable
quantification by mass, at concentrations within one order of magnitude of the respective LOQ
for each analyte. Isotopic forms of each compound were spiked into each sample vial by mass.
Precision was assessed as %RSD for comparative purposes. Unaltered peak areas were used to
obtain “raw data” %RSD. This same data was then processed as a simple function of endogenous
to spiked peak areas (Pendogenous/Pspike). As seen in table 3.2, and represented graphically in figure
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3.5, analyzing by raw peak areas produced mean total %RSD across all analytes of 11.9%. When
the same data were processed by IDMS, mean total %RSD for all analytes improved to 4.2%.
Table 3.2: A comparison of reproducibility of raw chromatographic peak areas with IDMScorrected peak areas (n=5)
Analyte
Benzene
Toluene
o-Xylene
PCB-28
PCB-52
PCB-101
PCB-138
PCB-153
PBDE-47
PBDE-99
Chlorpyrifos
Metolachlor
Acetochlor
Pendimethalin
DEHP

%RSD Raw Data
30
17
14
14
11
7.3
9.2
11
3.3
6.0
9.8
7.0
19
10.1
10.8

%RSD IDMS Corrected
9. 4
5.3
5.7
4.5
2.3
3.6
4.1
2.0
3.0
1.4
5.7
2.0
8.5
0.812
6.12
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Figure 3.5: The comparison between relative standard deviation (%RSD, n=5) of all compounds
of interest quantified in blank-subtracted serum. Background represented the %RSD of raw peak
areas of all replicates, foreground represents %RSD of IDMS-corrected peak area
Significant improvements in sample-to-sample reproducibility observed in the IDMS data
were most reasonably achieved by compensating for analytical variance typically introduced to
the sample preparation and quantification. Many peer reviewed and EPA methods still in use
today define isotope dilution as an isotopic RF. Isotopic RF quantification relies on generating a
calibration curve that plots RF (between an endogenous compound and its isotopic analog)
versus concentration of endogenous standard.11 This approach differs from IDMS, in which no
calibration curves or RFs are generated. This way, IDMS eliminates the inexact nature of
calibration curves. By decreasing variance, IDMS quantification created confidence intervals that
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were narrower than those obtained by analysis of raw data, allowing for potentially actionable
diagnostic results.

3.4.3 Comparison with Existing Methods
Single step extraction was compared with the traditionally accepted extraction method of
SPME using both isotopic RF and IDMS mass spectrometry quantification of PCB-52 in 200 L
of blank-subtracted serum. Figure 3.6 shows that SPME coupled with isotopic RF quantification
produced inaccurate quantitative values with poor reproducibility. The addition of IDMS
quantification to SPME improved accuracy from 24.6% to 9.66% error and precision from
16.9% to 5.61% within-run RSD. Single bar SBSE improved the accuracy over SPME from
9.66% to 6.07% error and increased the precision from 5.61% to 5.40% RSD. Single bar SBSEIDMSMS significantly improved quantitative accuracy and precision, compared with industryaccepted SPME and calibration curves. A reasonable explanation for the improvements in
SPME-IDMS over SPME-RF is the ability for IDMS to reduce or eliminate many errors
associated with sample preparation and analysis once isotopically labeled analog and naturally
occurring analyte are in equilibrium.
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Figure 3.6: A comparison of single bar SBSE and IDMS with existing, industry-accepted
methods of extraction and isotopic quantification. The 95% CI (n=5) is shown. Uncertainty of
the calculated concentration is shaded.
3.4.4 Accuracy at Limit of Quantification
Data quality approaching a limit of quantification (LOQ) was assessed for both RF and
IDMS quantification using PCB-52 and a quantification limit of 0.111 ng/g. Data was obtained
by spiking isotopic and varying concentrations of endogenous PCB-52 into 200 L of blanksubtracted serum and analyzing by single bar SBSE-IDMS. An isotopic RF calibration curve was
generated for the endogenous compound at values 40% to 4000% above LOQ with n=5
replicates at each point. This data was then processed by IDMS using data obtained from the
same analyses. Figure 3.7 shows that the RF data lost quantitative accuracy below 25 ng/g (two
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order of magnitude above the IDMS quantification limit) with a mean within-run %RSD of
10.6%. When the same data was processed by IDMS, all data points maintained quantitative
accuracy with a mean within-run %RSD of 2.28%.

Figure 3.7 A comparison of IDMS and RF quantifications approaching the PCB-52
quantification limit, showing 95% CI (n=5). Uncertainty of the certified value (5%) is shaded.
As suggested by theory, it was observed that calibration accuracy and precision worsened
approaching the limit of quantification.12 The calibration curve does not match the certified
concentration below 25.0 ng/g. This work demonstrated the capability of IDMS to maintain
quantitative accuracy, validity, and reliability approaching the instrumental LOQ.
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3.4.5 Method Validation
Concentrations of all analytes were experimentally determined in 200 L of blanksubtracted serum and compared at the 95% CI against certified standards traceable to the
National Institute of Standards and Technology (NIST). All quantified POPs were statistically
identical to the NIST traceable certified concentrations, proving accurate quantification. A
complete description of scientifically relevant chemical characteristics and figures of merit of the
single bar SBSE-IDMS mass spectrometry method can be found in table 3.3. All data were
obtained from analyses of samples containing endogenous and isotopic compounds spiked into
blank-subtracted serum using an analytical balance. The calculated value represents the
concentration of endogenous compounds present in the spiked serum prior to analysis calculated
from the initial concentrations of NIST-traceable standards. Across all analytes, average
accuracy exhibited 4.10% error with an average precision of 4.28% RSD.

Table 3.3: Figures of analytical merit comparing concentration values obtained by S-SBSEIDMS (n=5) in blank-subtracted serum with calculated concentrations. Unless noted, all
concentrations are in units of μg/g
Analyte

†

†,‡

Benzene
Toluene
o-Xylene
PCB-28
PCB-52
PCB-101
PCB-138
PCB-153
PBDE-47
PBDE-99
Chlorpyrifos
Metolachlor
Acetochlor
Pendimethalin
DEHP

2.3
2.69
3.12
5.62
5.84
7.07
6.83
6.68
6.81
6.5
5.11
3.13
3.12
5.18
7.5

7.12
6.47
6.03
0.731
0.731
0.731
0.731
0.731
-0.602
-0.602
0.426
0.239
0.656
0.669
-1.08

Log Kow

Log VP

Calculated
Value
9.14±0.46
6.34±0.31
11.0±0.55
1.33±0.067
1.33±0.67
1.33±0.67
1.33±0.67
1.33±0.67
0.531±0.027
3.27±0.16
1.70±0.085
1.86±0.093
2.10±0.11
0.641±0.032
0.610±0.030

†

§

Experimental
Value
9.77±1.1
5.93±0.39
11.1±0.77
1.27±0.070
1.29±0.036
1.28±0.056
1.29±0.065
1.27±0.031
0.503±0.018
3.28±0.057
1.64±0.11
1.80±0.044
2.25±0.23
0.624±0.0062
0.562±0.075

|%Error|

%RSD

LOQ (ng/g)

6.89
6.47
0.908
4.51
3.01
3.76
3.01
4.51
5.27
0.306
3.53
3.23
7.14
2.65
7.87

9.4
5.3
5.7
4.5
2.3
3.6
4.1
2.0
3.0
1.4
5.7
2.0
8.5
0.81
6.1

163
29.7
6.41
2.46
0.111
0.159
0.309
1.26
1.49
1.71
0.0648
0.193
30.1
0.0621
1230

Chemical values taken from material safety data sheets
Vapor pressure
§
Experimental values determined with n=5 replicates showing 95% CI
‡
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This research specifically focused on the quantification of a selected group of
environmental toxins. However, the mechanism of SBSE is governed by the octanol-water
partition (Ko/w) of an analyte, extraction phase volume, and sample volume.2 It is, therefore,
reasonable to propose that, using identical sample volumes and stir bars, this method could be
expected to produce similarly high-quality data when expanded to analytes of Ko/w values within
the range of those included in this work (log Ko/w 2.3 - 7.5). The validated method developed in
this work was specifically optimized for the selected list of analytes; however, the mechanisms
of extraction, separation, and quantification could allow a universal application to POPs of
similar chemical characteristics.

3.4.6 Inter-Laboratory Analytical Method Transfer
Transfer of method quality to an independent laboratory, as demonstrated in figure 3.8,
produced results that were statistically comparable to the results obtained at the primary
laboratory at the 95% CI. A chemically diverse suite of analytes was chosen to test robustness of
the method transfer. Total within-laboratory reproducibility for the primary laboratory across all
selected analytes was 2.52% RSD; the independent laboratory achieved total within-laboratory
reproducibility of 1.32% RSD.
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Figure 3.8: Percent difference in concentrations obtained for select compounds by a secondary
analyst in an independent laboratory compared with the validation data obtained in the primary
laboratory, showing 95% confidence of primary lab (shaded area) and secondary lab (bars)
In commercial, clinical, and government laboratories, inherent biological variability is
often compounded by poor analytical reproducibility introduced by necessary, but complex,
sample preparation steps.13 In these labs, emphasis has been placed on development of simple
analytical procedures that use small volumes of blood serum to obtain high accuracy, actionable
results.14 Such analyses require methods that are statistically accurate, highly reproducible, and
efficient. Highly complex sample preparation steps may be reproduced by expert analysts. But,
by compensating for much of the potential variance introduced in sample preparation, this
method has demonstrated the potential to be transferred between laboratories and analysts with
approximately two hours of operational training.
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3.4.7 Assessment of Clinical Potential and Generalized Findings
The high accuracy and transfer capability of this optimized method are directly applicable
to clinical chemistry, among other fields. As a proof of application, this section will detail
analytical improvements in two recent IRB-approved collaborative studies with The Children’s
Institute of Pittsburgh (TCI) that investigated exposure to environmental toxins in children. In
the first, existing methods using SPME were optimized for use with IDMS quantification.
Multiple peer-reviewed sources claimed to improve sample-to-sample SPME reproducibility in
blood serum.15,

16

However, these methods were unable to be replicated in this laboratory for

serum-immersive SPME analysis. The analytical incompatibility of SPME with immersive
extraction from complex matrices such as serum and plasma necessitated the development of
new methods for the analysis of POPs in small volumes of serum. The second study used SBSE
and IDMS together to quantify a suite of organic toxins. Comparing the average quantifiable
concentration of toluene, o-xylene, PCB-138, and PCB-153, (toxins included in both studies)
figure 3.9 demonstrates the improvement in LOQ afforded by single bar SBSE-IDMS (mean
LOQ=9.14 ng/g) over SPME-IDMS (mean LOQ=57.5 ng/g), which allowed quantification of
biologically relevant concentrations of POPs. Analyzing by SPME-IDMSMS only quantified the
greatest outliers.
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Figure 3.9: Mean toxin concentrations obtained using SBSE-IDMS, comparing mean LOQ of
SBSE-IDMS and SPME-IDMS for POPs quantified in both studies.
To obtain actionable results and discern variable changes from clinical analyses, high
quality data must be obtained with narrow confidence intervals. National and regional
laboratories are often equipped to produce similarly high quality data for large populations.
However, in this age of increasingly personalized medicine, local academic, clinical,
commercial, and government laboratories must be capable of generating the same highly reliable
and reproducible data. Observed in figure 3.10, using metolachlor as an example, this method
allowed for the identification of statistically outlying individuals when population and subpopulations showed no statistical deviation from national average.
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Figure 3.10: Mean difference from national average of metolachlor in regional collaborative
study, 95% CI shown (n = 30x5, 27x5, 15x5, 5, respectively). Grey bar represents 95%
confidence of national average.
The high throughput afforded by the increased efficiency and reduced sample preparation
of this method enabled the generation of population and sub-population data for inter- and intracomparison purposes. The reliability and sample-to-sample reproducibility of this method
enabled high quality individualized analysis to be performed as well. The ability to reliably
transfer among and between laboratories could allow local laboratories, with traditionally fewer
resources than national laboratories, to generate the same high quality, reliable, and reproducible
data.17
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3.5 Application of Developed Method to Environmental Samples: EPA 625 Update
This section will describe experiments to improve upon existing EPA method 625, a
standard method for the analysis of wastewater, by removing the necessity for large volumes of
solvents required by outdated liquid-liquid extraction protocols of Method 625. Current methods
for wastewater and drinking water are described including the research objectives for removal of
liquid-liquid extraction and harmonization between differing methods and techniques.

3.5.1 Discussion of Wastewater Sample Preparation for GC-MS Analysis
The existing method for the quantification of organic pollutants in municipal and
industrial wastewater was developed in the 1980s and requires the use of liquid-liquid or Soxhlet
extractions.18 Regardless of the scientific progress of the previous decades to reduce solvent
consumption and waste generation, laboratories certified by the EPA for wastewater analysis are
bound by the regulations of EPA Method 625, which requires 0.5L sample volumes and up to
250 mL of a liquid-liquid extracting solution containing hexane, methylene chloride, and
acetonitrile.
The EPA has also produced methods for the quantification of organic pollutants in
drinking water: EPA Method 525 (and the updated EPA Method 526).19, 20 Method 525 removes
the stipulation of liquid-liquid extraction and permits the use of solid-phase extraction columns
or cartridges. While this has freed laboratories to remove the waste-generating liquid-liquid
extractions, the title of the method still specifies liquid-liquid as the extraction technique. In the
1990s, the EPA developed and produced EPA Method 526, a method that specifically names
SPE as the extraction technique of choice and removes “liquid-liquid extraction” from the
Method title. EPA Method 525 contains a larger analyte-list by a significant margin and, as such,
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is the Method utilized by a large number of laboratories. As the two methods exist for the
quantification of chemically similar analytes, many commercial laboratories are only certified for
Method 525. This means that, while Method 526 exists as a “greener” alternative to the wastegenerating Method 525, additional and continued work is being done to include solid-phase
extraction techniques into existing EPA Methods.
Much has been written already on the differences and similarities between Method 625
and 525, but several important differences must be noted.21 The compound lists between the two
methods are significantly different, however this is primarily a result of the times in which the
two methods were developed, and not based in scientific need or industry regulation. Due to
existing regulations, Method 625 analyte-list was never expanded. Instead, a third method was
developed for a dramatically expanded list of organic pollutants in water, EPA Method 8270 for
the analysis of groundwater and hazardous waste water.22 As Method 8270 was based on Method
625 sample preparation protocol, albeit with a significantly expanded analyte-list, the stipulation
for liquid-liquid extraction remained. While each of these three methods is overseen by a unique
department within the EPA, 625 and 525 are both regulated by Section 304(h) of the CWA,
further enabling their harmonization.23 While similar in breadth and object, Method 8270 is a
Resource Conservation and Recovery Act (RCRA) method of analysis, under SW-846
guidelines, and Methods 625 and 525 are governed by the office of water and Clean Water Act..
SW-846 is a compendium consisting of hundreds of methods and guidelines for analytical
procedures governing the analysis of wastes.. The division between SW-846 methods and CWA
methods has created a scenario in which standardized methods, with often similar aims,
objectives, and analyte lists, can contradict one another in significant ways. Harmonization of
standardized government methods is the ultimate objective of updating Method 625.
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In the era in which these three Method were originally developed, fewer options existed
for SPE of analytes of extremely high or low hydrophobicity, eliminating the incentive to
remove liquid-liquid extraction- a method capable of extracting an extremely wide range of
hydrophobicity analytes. More modern SPE technologies exist that are more capable of
replicating the breadth, accuracy, precision, and sensitivity of liquid-liquid extractions.24
The purpose of this extended application of the developed S-SBSE-IDMS method
described above was to demonstrate the feasibility of applying SPE techniques present in
Method 525 to samples covered by Method 625, the first step in eventual method harmonization.
Ultimately an updated 625 method will be produced with these SPE alternatives and lists of
appropriate SPE materials, appropriate analytes and method parameters that enable this transition
to SPE and a move away from older and less green liquid-liquid technology. The demonstration
of SPE was accomplished via two experimental accomplishments. The first aim of these research
demonstrations highlighted the robustness of the developed S-SBSE-IDMS method by the
production of validated analytical data in wastewater (a separate yet complex solution from
blood serum). The second demonstration and aim of this work was to provide recommendations
to the EPA, through an involvement with a collaborative working-group consisting of 23
laboratories from government, industry, and academia, on the update of EPA Methods 625. To
accomplish these aims, the previously developed S-SBSE-IDMS method was validated for the
differing analytes and potential matrix effects using EPA recommended validation parameters.
Second, the validated method was assessed for feasibility of inter-laboratory method transfer.
Finally, the method was compared against the methods developed by collaborative working
group as a whole and with the other working group laboratories using SBSE to gauge the
effectiveness of S-SBSE-IDMS.
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3.5.2 Methods and Instrumentation
For method development, the total analyte list from EPA 625 was reduced to a list of 21
compounds, representing the wide range of chemo-physical differences present in the full analyte
list. For method transfer experiments, two sets of randomly selected analytes were prepared into
solution of synthetic wastewater and shipped, with all required GC/MS and quantitative software
methods and standard operating procedures, to two independent laboratories with separate
analysts for comparison with results achieved by the author in the primary laboratory at
Duquesne University.
Instrumental parameters were set to the recommendations of EPA Method 625.
Extraction and quantification procedures were described previously for S-SBSE-IDMS of blood
serum samples. The instrumental steps were partially automated using the GERSTEL MPS II,
Agilent 7890A GC and an Agilent 5975C mass spectrometer. Agilent Masshunter software was
used to determine the peak area of each analyte and its isotopically labeled counterpart at the
quantitative m/z ions listed in table 3.4. Quantitative m/z values for the natural analytes were
acquired from EPA Method 625 and isotopic m/z values were acquired experimentally. Using
acenaphthylene and 13C8-acenaphthylene at examples, figure 3.10 demonstrates the mass spectra
corresponding to a naturally occurring molecule (a), isotopically enriched analog (b), and a
mixture of both natural and isotopically enriched.
Compound identification was performed by analysis of mass spectra for the quantitative
and confirmatory m/z fragments of the analytes of interest. Identification of quantitative and
confirmatory peaks for isotopic analogs involved altering the quantitative m/z spectral peak of
the naturally occurring compound by the addition of mass units equal to the number of isotopic
enrichments located on the quantitative molecular fragment. For an example, figure 3.11 shows
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the identification of acenaphthylene by the presence of the quantitative m/z peak at 152 and the
confirmatory peak at 153 m/z. The mass spectrum for

13

C8-acenaphthylene (middle) was

identified by the quantitative peak at 160 m/z and the confirmatory peak at 161 m/z. A mixture of
the two analogs (bottom) displays both quantitative peaks and confirmatory peaks.

Figure 3.11 Mass spectrometric analysis showing the quantitative and confirmatory m/z peaks of
(top) naturally occurring acenaphthylene, (middle) isotopically enriched 13C8-acenaphthylene,
and (bottom) a mixture of both analogous forms of acenaphthylene
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Table 3.4: Quantification ions for natural and isotopic molecules with respective
chromatographic retention times (R.T.)
Analyte
B-BHC
1,2,4-Trichlorobenzene
4,4-DDD
4,4-DDT
Acenaphthene
Aldrin
Anthracene
Benzo[a]pyrene
Benzo[k]fluoranthene
Benzyl buty lphthalate
Bis(2-ethylhexyl)phthalate
Di(benzo[a,h])anthracene
Diethyl phthalate
Dimethyl phthalate
Fluroranthene
Hexachlorobenzene
Hexachlorobutadiene
2-Chloronaphthalene
Pyrene
Naphthalene
Phenanthrene

Quantitative Ion (m/z)
Isotope
Natural
187
181
183
180
243
235
247
235
164
154
270
263
184
178
264
252
264
253
264
253
153
149
292
278
125
121
167
163
172
166
290
284
229
225
170
162
208
202
134
128
184
178

Approximate R.T. (minutes)
21.6
12.5
27.7
28.6
17.6
24.4
22/22.1
33.4
32.7/32.6
32.7/32.6
30.45
35.7
19.29
17.17
19.2
21
13.1
15.9
42.7
12.67
22/22.1

3.5.3 Wastewater Validation Results
Samples of synthetic wastewater spiked at unknown concentrations of all listed analytes
were sent to all working-group participating laboratories for validation of various SPE
techniques. Figure 3.12 shows the accuracy and precision achieved by the S-SBSE-IDMS
compared with the “actual” values obtained by the EPA certified laboratories using EPS Method
625 by plotting percent difference of the experimental values obtained by S-SBSE-IDMS from
the EPA-certified laboratory. EPA-certified results were used for comparison and validation.
Using these results, however, provided an additional level of validation for SBSE-IDMS. The
EPA-certified laboratories (upon which the “actual” values were based) achieved a mean
precision (95% confidence) of ±54.1%, while the S-SBSE-IDMS method in this laboratory

82

produced a mean precision (95% confidence) of ±17.6%. A significant finding in this work was
that IDMS, when compared with the EPA-certified laboratories using EPA Method 625,
generated only positive bias in quantitative error. The source of this bias, whether due to a bias in
the experimental method or due to error introduced by the EPA laboratories, will be investigated
in future work.

Figure 3.12: Mean concentration values obtained using the developed S-SBSE-IDMS method,
showing percent difference from “actual” value obtained by EPA certified laboratories using
EPA Method 625, showing 95% confidence limits of the mean from this lab (bars) and the mean
precision of the EPA-certified laboratories (shaded area: 54.1%)
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The accuracy and precision values obtained using S-SBSE-IDMS fall within the
stipulated regulations enforced by the EPA. For each analyte listed in EPA Methods 625, 525,
and 8270, analyte-specific QC acceptance criteria are provided within the method. Mean
accuracy required for Method 625 is approximately ±60% error, with mean required precision
approximately ±30% RSD (and up to 98% RSD for many analytes). These acceptance criteria
are very broad and can likely be improved with the addition of up-to-date analytical techniques
and quantitative procedures. Validation figures can be found in table 3.5. The validated method
presented here was capable of significantly improving the precision of quantification at 95%
confidence, from ±54.1% to ±17.6%, a significant difference at p=0.0223.

Table 3.5: Validation figures for the quantification of selected EPA 625 analytes in synthetic
wastewater, showing %difference from EPA-certified values
Analyte
1,2,4-Trichlorobenzene
4,4-DDD
Acenaphthene
Aldrin
Anthracene
Benzo[a]pyrene
Benzo[k]fluoranthene
Benzobutyl phthalate
Beta-BHC
Bis(2-ethylhexyl) phthalate
Dibenzo[a,h]anthracene
Diethyl Phthalate
Dimethyle phthalate
Fluoranthene
Heptachlor
Hexachlorobenzene
Hexachlorobutadiene
Naphthalene
Phenanthrene

%Difference
28.2
40.1
29.0
62.3
51.9
45.7
65.1
43.1
23.7
63.5
50.8
30.4
23.3
36.2
62.2
45.5
75.2
35.5
46.9

%RSD
10
17
17
13
4.5
18
12
12.
7.5
12
19
3.4
1.7
16
21
9.0
18
7.6
16

LOQ (ng/mL)
2.98
22.16
6.08
3.23
2.95
20.26
41.23
17.2
15.53
18.01
35.11
151.8
2.45
2.61
2.72
1.14
3.13
1.64
2.22

LOD (ng/mL)
1.79
13.3
3.65
1.94
1.77
12.16
24.74
10.32
9.32
10.81
21.07
91.08
1.47
1.56
1.63
0.68
1.88
0.98
1.33

%Difference: Percent error from the concentrations generated by EPA-certified labs
LOQ: Limit of quantification as defined by a 5:1 signal to noise ratio.
LOD: Limit of detection as defined by a 3:1 signal to noise ratio.
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3.5.4 Inter-laboratory Analytical Method Transfer
Two sets of synthetic wastewater were prepared in the primary laboratory and spiked
with randomly selected amounts of ~10 analytes chosen from the EPA Method 625 analyte list.
Figure 3.8 shows the results of the first laboratory method transfer experiment via flash storage
device containing GC/MS and quantitative software and standard operating procedures. In figure
3.13, percent difference is shown between concentration values obtained by the independent
laboratory compared with the primary laboratory. The transfer was highly effective, producing
6.85% mean difference from the primary laboratory results, and 7.95% mean intra-laboratory
%RSD. Quantifying this reduced analyte list, the primary laboratory produced a mean intralaboratory precision of 2.11% RSD.
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Figure 3.13: Demonstration of effective laboratory method transfer into a second laboratory,
showing percent difference from concentrations obtained in the primary laboratory and 95%
confidence levels. Mean 95% confidence achieved in the primary laboratory is shaded in blue.
A second method transfer experiment was performed by again transferring both GC/MS
methodology/quantitative software and standard operating procedure to an independent
laboratory with a unique analyst (different from transfer experiment 1). Results of this method
transfer experiment can be found in figure 3.14. Mean percent difference from the primary
laboratory concentration values was 6.28%, with a mean intra-laboratory %RSD of 5.10%. For
this set of analytes, the primary laboratory produced a mean intra-laboratory precision of 5.02%.
Both method transfer experiments produced quantitative values that were statistically
indistinguishable from the primary laboratory, effectively transferring the expertise of the
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primary laboratory digitally. The differences observed in the secondary and tertiary laboratories
from the primary laboratory were equally divided between positive and negative differences,
indicating no distinct positive or negative bias. Both sets of method transfer experiments resulted
in significant positive error, with the receiving laboratory reporting quantitative data with
positive error in all cases. The source of this bias, being non-random in nature, will be
investigated in future research. One potential source of this bias is the loss of natural analyte by
glass-wall adhesion during shipment to the receiving laboratory, resulting in uniform positive
bias in all samples analyzed by receiving laboratory.

Figure 3.14: Figure 3.8: Demonstration of effective laboratory method transfer into a third
laboratory, showing percent difference from concentrations obtained in the primary laboratory
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and 95% confidence levels. Mean 95% confidence achieved in the primary laboratory is shaded
in blue.
3.5.5 Analysis of Unknown Wastewater Samples
The developed method, validated against EPA-certified concentrations, was
applied to the analysis of wastewater samples spiked with unknown concentrations of EPA
Method 625 analytes in a blind study performed by the collaborative working-group. The
accuracy achieved in this work surpassed the accuracy achieved by laboratories analyzing via
SBSE-calibration curve, but this improvement in accuracy was not statistically significant
(p=0.643). This laboratory achieved higher accuracy quantification than the rest of the pooled
laboratories that used traditional SPE columns and cartridges (n=21) at a statistically significant
level (p=0.019).
All laboratories using SBSE, including IDMS and calibration curve quantifications,
achieved higher mean accuracy than the rest of the SPE laboratories, but outside of the cut-off
for statistical significance (p=0.068). These results indicate that SBSE may provide an
improvement in accuracy over traditional SPE for the analysis of synthetic wastewater by EPA
Method 625, but only when SBSE was combined with IDMS were the improvements in accuracy
over traditional SPE statistically significant. Table 3.6 shows a comparison of quantitative
accuracy for analytes that were quantified by all laboratories. As many laboratories did not report
values which fell below laboratory-specific LOQ values, only the analytes for which complete
data-sets were available were chosen for this comparison as to not bias the results.
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Table 3.6: Comparison of method accuracy against a laboratory analyzing by SBSE, and against
the rest of the study
Analyte
Acenaphthene
Anthracene
Hexachlorobenzene
Benzo(k)fluoranthene
Di-n-butylphthalate
1,2,4-Trichlorobenzene
Pyrene
Mean

%Mean Difference from EPA-Certified Value
Duquesne
SBSE-Lab
All Labs
15.8
1.28
29.4
4.27
42.2
41.7
4.47
8.59
35.9
18.7
26.4
29.1
31.5
21.8
23.8
37.7
31.3
39.8
4.35
10.2
26.5
16.7
20.2
32.3

The quantification values achieved by this laboratory were produced in three different
water matrices: synthetic wastewater (WW), synthetic wastewater with 20% acetonitrile matrix
modification (WW+ACN), and drinking water (DI). The three matrices produced statistically
similar concentration values for all measured analytes, excluding the analyte isophorone. Figure
3.15 shows a comparison of the quantitative values achieved by this laboratory in three separate
matrices, showing statistically significant agreement. Isophorone was not an EPA 625 compound
spiked into the unknown mixture. It is primarily used as a solvent in printer ink, paints,
adhesives, lacquers, coatings, and finishings and was discovered to be a significant contaminant
in the Duquesne laboratory, but not in either of the method transfer receiving laboratories.
Routes of contaminant introduction in the primary laboratory were limited due to the filtration
system instrumental enclosure installed around the GC/MS and sample handling system. The
likely introduction route was during the sample preparation step when the sample was exposed to
ambient, unfiltered laboratory air. Isophorone was not present in the coatings applied to the
flooring, the wall paint, and the lacquer used on the filter system enclosure. Future sample
preparation work must be performed in the ISO Class 5 cleanroom to prevent further sample
contamination.
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Figure 3.15: Quantitative values achieved for the studied EPA 625 analytes in three separate
matrices, showing 95% confidence. The contaminant isophorone was quantifiable in all three
matrices in the primary laboratory at Duquesne, but not at either receiving laboratory
The three solutions were extracted using identical methods for determining matrix
effects. The similarity between drinking water recovery and wastewater recovery suggests that
the method was able to correct for any wastewater matrix effects that may have been present.
The comparison between WW and WW+ACN samples was important to determine if the WW
samples were being biased by the presence of a immiscible solvent from the isotope-spiking
procedure. The WW+ACN samples eliminated the single droplet of immiscible solvent but
produced a cloudy solution, suggesting that the immiscible solvent did not dissolve, but simply
created an emulsion of suspended micro-droplets in the solution. While further work is necessary

90

to determine the exact effects of the immiscible solvent and of the acetonitrile matrix
modification, both WW and WW+ACN produced statistically indistinguishable quantitative
results. This effect is discussed in detail in Section 3.4.6.

3.5.6 Limitations and Future Outlook
The primary limitation to this work that may have contributed to the relatively poor
sensitivity of the highly hydrophobic compounds was the spiking of isotopic solution for IDMS
into the aqueous samples. Care was taken in this work to maximize the concentration of isotopic
stock solutions to minimize spike volume; however, due to the highly hydrophobic nature of
many of the EPA Method 625 compounds, stock preparation required the use of hexanes and
toluene for dilutions. Research was performed on stock preparation using the aqueous-miscible
solvents acetone, methanol, and acetonitrile. However, the low Ko/w of these solvents prevented
the solvation of high concentrations of many EPA Method 625 analytes. Additionally, these
solvents would not provide stability of time during storage, as the interaction between the glass
container and the analytes would be stronger than that of the solvent and analyte.
Upon spiking microliter volumes of stock isotopes into the wastewater or drinking water
samples, a small volume of immiscible solvent tended to form at the top of the solution.
Theoretically, this immiscible solvent possessed similar properties to single-droplet extraction
methods. Many of the analytes of interest in this research likely equilibrated between the
aqueous solutions, the immiscible droplet, and the stir-bar, reducing the overall amount of
compound present in the stir bar. As discussed in Section 3.4.5, the WW and WW+ACN samples
produced statistically identical results, indicating that the solvent droplet did not influence the
recovery, that IDMS was able to correct for the reduced recovery, or that matrix modification by

91

acetonitrile had no effect on improving recovery. This is not the only reasonable explanation for
the relatively poor sensitivity of the highly hydrophobic compounds however. Incomplete
thermal desorption from the stir-bar, particularly of the high Ko/w, low volatility compounds,
could also reasonably explain the observed issues with sensitivity. While the LOD and LOQ for
all studied analytes fell well below the required values specified in EPA Method 625, future
studies on SBSE-IDMS with highly hydrophobic compounds should consider further
investigation of the effects of spiking immiscible solvents into aqueous solution.

3.6 Conclusions
This S-SBSE-IDMS method was the first to combine the enhanced analyte recovery and
sensitivity afforded by SBSE with the improvements in accuracy and precision attained by IDMS
quantification. This method was novel in that it was the first to simultaneously extract both
volatile and nonvolatile environmental pollutants simultaneously from microliter volumes of
serum. This was a major improvement over existing methods, allowing researchers to reduce
sample consumptions and improve the efficiency of consumable usage. The developed method
was optimized and validated for biological research on blood serum to determine the organic
pollutant body-burden of an individual using a high-quality analytical method. Comparing this
validated method with existing, industry-accepted method like SPME and SPME-calibration
curve demonstrated the significant improvement afforded by S-SBSE-IDMS in both its potential
as a research tool and in a practical clinical application.
The validated S-SBSE-IDMS method was the applied to a separate, but similarly
complex, sample: industrial wastewater. While the sample matrix used for this research was
synthetic wastewater, the matrix possessed many of the confounding characteristics of real world
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wastewater. The S-SBSE-IDMS method produced EPA-validated quantification results of higher
quality than all other laboratories using similar SPE technologies. The high-quality data
produced by this method in analysis of unknown wastewater samples will be included in
recommendations to the EPA, in collaboration with a 23-laboratory working-group, on methods
and techniques to effectively update the regulations and standards for industrial and municipal
wastewater analysis, to align these regulations more closely with current drinking water analysis
standards.
This method was validated for the analysis of environmental pollutants in two unique, but
equally complex, sample matrices. In both sets of experiments, the analytical quality of the SSBSE-IDMS method surpassed existing methodologies and technologies. Likewise, specific
emphasis was placed on eliminating complex sample preparation steps to produce a final method
capable of being transferred between laboratories and analysts while maintaining analytical
quality. This research has produced a highly accuracy, highly precise analytical method capable
of maintaining analytical quality when transferred digitally between and among laboratories and
analysts. These method characteristics are invaluable to future work in both clinical and
environmental analyses.
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Chapter 4: Relationship between organic pollutants and autism severity in children with
autism and neurotypical peers

4.1 Introduction
Emergent data have implicated environmental exposure, evidenced by serumconcentrations of specific environmental pollutants, as a correlative factor in the etiology of
numerous non-communicable diseases, such as autism spectrum disorder (ASD), heart disease,
diabetes, and lupus.

1-4

Exposure to heavy metals and organic pollutants, collectively termed

xenobiotics, has been linked with neurodegenerative diseases, including Parkinson’s and
Alzheimer’s diseases, suggesting the central nervous system is specifically susceptible. 5, 6
Much environmental and exposomic research is epidemiological in nature. Concern has
been expressed about agreement between self-reported and clinically assessed values in
epidemiological studies, particularly with rare health events.

7, 8

Many studies tend to rely upon

proxy measurements, such as written surveys, interviews, or self-report, to establish exposure.
Studies have found that the use of proxies can introduce bias into methodological outcomes
when self-reported measurements are used in lieu of direct clinical assessments.

7, 9

While

epidemiological and exposomic studies have suggested that neurological symptoms can be
correlated with pre- and post-natal exposure to environmental pollutants, direct quantitation of
environmental pollutants is necessary to eliminate the potential for proxy bias.
In biological fluids, analytical quality is often hindered by inherent biological variability
as well as complex sample preparation and analytical procedures. Further, calibration curve and
internal standard quantifications are inherently unable to correct for sample-to-sample variability
and errors introduced into quantification by extraction, sample preparation, and instrumental
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analysis. This quantitative variability can be improved using direct quantitation techniques like
IDMS.

10, 11

High-throughput sampling and direct-quantitation methodologies were utilized in

this work to achieve high accuracy and precision and to correct for error introduced by sample
preparation, chromatography, and mass spectrometry. These technologies allow researchers to
accurately quantify environmentally relevant concentrations of organic pollutants. 11, 12

4.1.1 Hypothesized Autism Spectrum Disorder Pathophysiology
A hypothesis has been proposed that suggests a portion of the pathophysiology of ASD
may relate to interactions between physiology and the environment in genetically predisposed or
otherwise susceptible individuals.13,

14

A fundamental expectation in this hypothesis is the

observation of differential physiological response to similar environments by susceptible
individuals compared with typical controls. A number of pathways have been proposed to
explain this physiological/environmental interaction hypothesis, focusing primarily on impaired
methylation and detoxification that can lead to glutathione-redox imbalance and central nervous
system excitotoxicity. Studies have discovered each of these features in individuals with ASD. 13,
15-18

Methionine (Met) is an essential amino acid that acts as a methyl group donor to facilitate
cellular methylation to, in part, protect, stabilize, and epigenetically activate or deactivate DNA.
Environmentally-sourced xenobiotics have been shown to inhibit the activity of methionine
synthase (MS) 19, the enzyme responsible for converting homocysteine to Met. Exposure to some
xenobiotics may, therefore, reduce cellular methylation capabilities in numerous systems that
require Met. One important methylation pathway is dopamine-stimulated phospholipid
methylation (PLM), which utilizes a D4 subtype dopamine receptor that is critical for
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synchronization of brain activity during attention.

20, 21

This suggests that xenobiotic impairment

of MS could limit dopamine-stimulated PLM, leading to impairments in neuronal
synchronization and attention, key features found in children with ASD. 13, 22
Detoxification is the process by which xenobiotics are removed from the body and is
dependent on Met and MS for many necessary functions. The primary antioxidants, Met and
glutathione (GSH), are sulfur-containing antioxidants that act as a primary pathway for removal
of xenobiotics from tissues, regardless of chemical identity.

23

Therefore, overall stress on

detoxification pathways may be more dependent on overall xenobiotic insult than on specific
xenobiotics. 13 Impaired MS activity, therefore, may limit the detoxification capacity of the body
by reducing sulfur-containing antioxidant pathways.
Met displays moderate antioxidant capacity and acts as a biochemical precursor to the
primary bodily antioxidant, GSH. Balance between reduced glutathione (GSH) and oxidized
glutathione (GSSG) has a broad impact on overall cellular health. Met protects GSH/GSSG
redox balance by preventing GSH depletion, as GSH is synthesized in a reaction involving Met.
An imbalance in GSH/GSSG and an increase in reactive species in the body is called oxidative
stress. Oxidative stress can allow xenobiotics, specifically organochloride pesticides and
polychlorinated biphenyls, to disrupt the neurotransmitters glutamate and gamma-aminobutyric
acid (GABA) and lead to central nervous system excitotoxicity, which can exacerbate symptoms
of ASDs.

15, 24

This suggests that impaired MS activity could create competition for available

GSH in the GSH/GSSG redox-cycle,
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resulting in increased oxidative stress and greater

potential for central nervous system excitotoxicity.
Considering these atypical pathways discovered in individuals with ASD, the proposed
physiological/environmental interaction hypothesis suggests that a feedback cycle, triggered by
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environmental insult, may impair MS activity and affect multiple systems simultaneously by
decreasing methylation capabilities, inducing or exacerbating detoxification dysfunction, limiting
dopamine-stimulated PLM, and ultimately promoting excitotoxicity, leading to neurological
symptoms associated with ASD.
While some studies have implicated specific xenobiotics as correlative factors in ASD
etiology, this study sought to explore the combinative physiological effects of environmentally
relevant concentrations of multiple organic pollutants. With this objective, direct chemical
measurements of non-metabolized organic pollutants and behavioral rating scales/observations
were conducted in children diagnosed with ASD (n=30) and controls (n=30) matched by age,
sex, and socio-economic status in Western Pennsylvania to investigate the relationship between
organic pollutants and neurological symptoms associated with ASD.

4.2 Materials and Methodsfor the Study of Children with Autism and Controls
The study was approved by the Institutional Review Board (IRB) of Duquesne University
(Pittsburgh, PA, USA) (IRB #10-36) and was also conducted at The Children’s Institute of
Pittsburgh. All analysts involved with sample processing and chemical quantitation remained
blind to the identification and ASD-diagnosis status of all individuals throughout the course of
the study and data analysis.

4.2.1 Analyte Selection
Previous studies guided the selection of organic xenobiotics associated with etiology of
ASD.

14, 26

The selected analytes represented a wide range of volatility, chemical function, and

hydrophobicity. Three volatile organic compounds (VOC), benzene, toluene, and o-xylene; two
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alkanes, pentane and hexane; five polychlorinated biphenyls (PCB), IUPAC congeners 28, 52,
101, 138, and 153; two polybrominated diphenylethers (PBDE), IUPAC congeners 47 and 99;
two organochlorine pesticides, metolachlor and acetochlor; one dinitroanaline pesticide,
pendimethalin; one organophosphate pesticide, chlorpyrifos; one phthalate, bis(2-ethylhexyl)
phthalate (DEHP); and the chlorocarbon perchloroethylene were chosen for this research. Further
information concerning analyte selection is provided.
VOC and alkane xenobiotics are byproducts of incomplete combustion and are typically
markers of automobile exhaust. PCB production was banned in the U.S. in 1979 but the
ubiquitous nature and environmental persistence of PCBs has resulted in measurable
environmental background concentrations and acutely contaminated sites have been discovered
in recent years. The two organochlorine pesticides, metolachlor and acetochlor, are the most
applied pesticides in Western Pennsylvania by weight, used primarily on corn and soybeans.
Chlorpyrifos and pendimethalin are also highly used pesticides and they represent modes of
biological activity separate from the organochlorine pesticides. PBDEs are flame retardant
compounds used in furniture cushioning and carpeting. DEHP is a plasticizer widely used in the
production of PVC, glow sticks, and linoleum flooring.

4.2.2 Quantitative Methods and Instrumental Protocols
Serum samples were analyzed by stir-bar sorptive extraction. Chromatography and mass
spectrometry were conducted using an Agilent 6890 Gas Chromatograph – 5975 Mass
Spectrometer system (Agilent Technologies, Santa Clara, CA, USA) with a non-polar column
(HP-5). Analytes were introduced into the GC-MS thermally using a thermal desorption unit
(GERSTEL GmbH & Co., Mülheim, Germany). Method blanks were run between replicates and
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instrument blanks between each new sample. Quantitation was accomplished using the standard
method of isotope dilution-mass spectrometry (IDMS).

10

Complete reagent, instrumental, and

quantitative materials and methods are provided.

4.2.3 Reagents
A standard containing six polychlorobiphenyl (PCB) congeners [2,4,4’-PCB (PCB-28),
2,2’,5,5’-PCB

(PCB-52),

2,2’,4,5,5’-PCB

(PCB-101),

2,2’,3,4,4’,5-PCB

(PCB-138),

2,2’,4,4’,5,5’-PCB (PCB-153), and 2,2’,3,4,4’,5,5’-PCB (PCB-180) as well as standards for
polybrominated diphenyl ether (PBDE) congeners [2,2’,4,4’-BDE (PBDE-47) and 2,2’,4,4’,5BDE (PBDE-99)] all at certified concentrations were purchased from Sigma-Aldrich (St. Louis,
MO). Benzene, toluene, o-xylene, (≥99% purity) and bis(2-ethylhexyl) phthalate (DEHP) were
purchased from Fluka (St. Louis, MO) at certified concentrations. Certified standards for
chlorpyrifos (99.5% pure), pendimethalin (98.8% pure), acetochlor (98% pure), metolachlor
(98.6% pure), toluene-d8, o-xylene-d10 were obtained from SPEX CertiPrep Group (Metuchen,
NJ). A certified standard for benzene-d6 was obtained from Cerilliant (Reston, VA).
Chlorpyrifos-d10 (99% labeled), tetrachlorethylene-13C2 (PCE) a standard mixture of PCB-13C12
(99% labeled, and standards for PBDE-47 and 99-13C12 (99% labeled) were obtained at certified
concentrations from Cambridge Isotope Laboratories, Incorporated (Tewksbury, MA).
Pendimethalin-d5 (98% labeled), acetochlor-d11 (98% labeled), metolachlor-d6 (98% labeled),
bis(2-ethylhexyl) phthalate-d38 (DEHP-d38), n-hexane-d14, and n-pentane-d12 were obtained from
C/D/N Isotopes Incorporated. (Pointe-Claire, Quebec, Canada).
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4.2.4 Subject Enrollment
The parents of thirty children aged 2-9 with autism or pervasive developmental disordernot otherwise specified (PDD-NOS) reviewed the inclusion and exclusion criteria with a research
coordinator. Following the policies outlined in the Common Rule of Responsible Conduct of
Research in Humans and the Declaration of Helsinki, parent consent was attained and child
assent was gained whenever possible. A psychologist with certification in autism diagnostic
observation schedule (ADOS) met with each child and a diagnosis of autism or PDD-NOS
allowed participation in the study. Each child was paired by age, gender, and household income
with a control child recruited by a flyer approved by the IRB. Following consent and child
assent, control children underwent a history and physical examination to rule out genetic,
developmental, neuropsychiatric disorders, and an immediate family member with ASD. Control
children then underwent identical ADOS evaluation, which confirmed the absence of autism.

4.2.5 Blood Draws
Approximately 30 mL of blood was drawn at the child’s home and processed for storage
within two hours. The blood was centrifuged and aliquots were separated into serum, plasma,
and red blood cells, before storage at −80 °C. All blood processing and analysis was performed
in a laboratory certified as an International Organization for Standardization Class-5 cleanroom.
The serum was processed from whole blood that was drawn using tubes specifically certified free
of volatile organic compounds.
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4.2.6 Behavioral Rating Scales and Observations
Behavioral rating scales were filled out by a parent or guardian. The rating scales
included the social communication questionnaire (SCQ), aberrant behavior checklist (ABC),
Gilliam autism rating scale (GARS), autism treatment evaluation checklist (ATEC), PDD
behavior inventory (PDDBI), and childhood autism rating scale (CARS). For analytical
comparisons, three ADOS observational results, including the communication and social domain
values, as well as the total ADOS score (a sum of the communication and social domain scores)
were determined at The Children’s Institute of Pittsburgh by a clinician with research level
certification in ADOS performance. 27-32
The ADOS is a widely accepted standard measure of deficits associated with ASDs.

33

Nomenclature at the time of the study supported a total score of 7 indicating the presence of
ASD. Research on the development of the ADOS found that individuals categorized in the most
behaviorally severe subset (termed “lower-autism”) had a minimum total ADOS score of 14.
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Therefore, this study utilized these ADOS-suggested categorizations, with a total score of 7
indicating the presence of ASD and a total score of 14 differentiating individuals into the most
behaviorally severe subset for data processing. This study’s data was accumulated prior to the
publication of Diagnostic and Statistical Manual V.

4.2.7 Validation and Statistical Assessment
Means and standard deviations were calculated using five replicate analyses. The lower
limit of quantitation (LOQ) was calculated as ten times the standard deviation of repetitive
measurements of the blank. All statistical comparisons were performed at the 95% confidence
interval (CI). Variance (σ2) was assessed as the square of standard deviation. Accuracy was
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evaluated by determining percent error from a certified value. For cohort comparisons, a
standard p-value cutoff was set as 0.05.
Validation was performed by spiking certified standards for each compound into blanksubtracted blood serum and analyzing by the above method. Experimental concentrations were
statistically compared with certified values.

4.2.8 Mean Xenobiotic Body-Burden and Exclusion Criteria
Concentrations of all xenobiotics quantified in an individual were pooled into one
variable, termed mean xenobiotic body-burden (MXB), for each individual. MXB was calculated
as the simple mean of all quantifiable analytes of interest for each individual. Usage of the
unweighted mean was chosen to reduce the risk of biasing MXB toward a particular compound
or chemical class. The MXB value of an individual averaged only those xenobiotics that were
quantified above the compound-specific LOQ. Following peer-reviewed methods for handling
missing variables in pooled data, individuals possessing quantifiable concentrations in <50% of
the studied xenobiotics were excluded from the MXB comparative analyses. 34

4.2.9 Linear and Logistic Regressions
Linear regression was performed on the separate cohorts to determine the relationship
between total ADOS score and MXB. Logistic regression was performed and all probabilities
were reported in decimal form. A peer-reviewed method for adjusting logistic regression for
rare-event data was used. 35 In this way, adjusted regressions were produced assuming 0.5%, 1%,
2%, or 3% national prevalence of the most severe autism diagnosis.
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4.3 Results and Findings
As described in Chapter 3, the analytical method was validated using blank-subtracted
serum spiked with certified concentrations of each studied xenobiotic prior to this study to assess
accuracy, precision, and limits of detection and quantitation. Full validation and LOQ data can
be found in Chapter 3. For all results and discussions, children with ASD are referred to as the
cohort with ASD or ASD cohort (n=30) and matched controls as the control cohort or controls
(n=30).

4.3.1 Qualitative Assessment of Exposure
All participants displayed unique patterns of non-metabolized xenobiotics in serum.
Many compounds were detected at levels below the analyte-specific LOQ but above the 3-to-1
signal-to-noise limit of detection.
Detection results can be found in figure 4.1, showing percentages of children with
detectable amounts of each specified xenobiotic in their serum and distribution of detection rates
between cohorts. Perchloroethylene, n-hexane, benzene, and toluene, were detected in >80% of
all children tested. Acetochlor, metolachlor, and pendimethalin were detected in >90% of the
children in the study. PCBs 153, 138, 52, 28, and 101 were detected in 50%, 17%, 14%, 12%,
and 9% of all children in the study, respectively.
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Figure 4.1: Percentage of the total population displaying detectable amounts of each compound,
showing portion of compound detected in each cohort
PCBs 28, 52, and 101 were detected in only the ASD cohort. PCBs 138 and 153 were
detected in 2.5-times and 2-times, respectively, more of the ASD cohort than controls. The
pesticides acetochlor, metolachlor, and pendimethalin were detected in a greater number of
controls than the cohort with ASD, 20%, 8%, and 4% greater, respectively. Overall, the cohort
with ASD contained a greater number of children with detectable levels of PCB and the control
cohort contained a great number of children with detectable levels of pesticides common to
Western Pennsylvania.
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4.3.2 Quantitative Cohort Comparisons
Full quantitative results and statistical tests for each xenobiotic by cohort can be found in
table 4.1. The pesticide metolachlor was quantified at a higher mean concentration in the control
cohort than the cohort with ASD (p=0.021). The pesticide pendimethalin trended toward higher
concentrations in the control cohort, outside of statistical significance (p=0.118). No other
significant differences were discovered between the two cohorts for any specific xenobiotic.

Table 4.1: Full quantitative results by cohort for all xenobiotics included in the study
ASD Cohort (μg/g)
Control Cohort (μg/g)
n
Mean (95% CI)
n
Mean (95% CI)
Benzene
4
0.263 (±0.13)
6
0.291 (±0.087)
Toluene
26 0.143 (±0.10)
28
3.32x10-2 (±1.34)
-3
o-Xylene
3
1.35x10 (±1.2)
0
Hexane
24 11.7 (±2.3)
29
9.44 (±0.81)
PCE
24 6.38x10-2 (±1.8)
27
5.64x10-2 (±2.5)
PBDE-47
1
0.00208 (N/A)
4
2.18x10-3 (±1.1)
-3
PBDE-99
4
7.19x10 (±5.0)
3
1.41x10-2 (±0.89)
Chlorpyrifos
10 2.27x10-4 (±1.1)
12
1.75x10-4 (±0.30)
-2
Pendimethalin 28 1.07x10 (±1.01)
29
2.01x10-2 (±5.4)
Metolachlor
28 5.18x10-3 (±2.8)
30
1.20x10-2 (±0.51)
Acetochlor
25 0.182 (±0.018)
30
0.160 (±0.026)
DEHP
19 3.95 (±1.7)
19
3.29 (±1.01)
Pentane
0
0
Pooled Mean 9
1.36 (±3.0)
9
1.21 (±2.4)
- Not enough replicates for calculation
*
Comparing concentration from ASD cohort to control cohort

p-value*
0.652
0.123
0.684
0.614
0.0987
0.891
0.118
0.021
0.695
0.697
0.846

Comparing the pooled mean of all compounds from the ASD cohort to the pooled mean
for all compounds in the control cohort yielded no significant difference (p=0.846). O-xylene,
PBDE-47, and PBDE-99 were quantifiable in <5 individuals in each cohort and were not
included in data pooling statistics to eliminate bias toward any specific compound, leaving nine
xenobiotics with which to compare quantitative variance.

108

The ASD cohort and controls both demonstrated significantly higher concentrations of
benzene, toluene, and DEHP (all p<0.0001), compared with concentrations found in a recent
national study.

36

Figure 4.2 shows a comparison between geometric mean concentrations

observed in a recent national study and statistical mean concentrations observed in this study for
the two cohorts.

Figure 4.2: A comparison between geometric mean national average concentrations and the
statistical mean concentrations observed for the cohorts in this study
A quantitative comparison between the two cohorts in this study with national study
averages for children of similar ages yields significant differences. Figure 4.3 demonstrates the
comparison between the three populations on a logarithmic scale. The children living in a similar
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geographic region (Pittsburgh, PA) demonstrated similar mean concentrations to each other, but
differed dramatically from the national averages for the selected compounds. Confidence
intervals were not included in this analysis due to the extremely wide range of concentrations
found within each population. The cohorts from this study demonstrated significantly greater
levels of benzene, toluene, and DEHP compared with the children in national studies.

Figure 4.3: Comparison between the two cohorts from this study and concentration values from
recent national study, without confidence intervals
4.3.3 Quantitative Variance
Detailed variance and relative standard deviation (%RSD) data can be found in table 2.
Overall, the cohort with ASD demonstrated a greater range of concentrations for most of the
110

xenobiotics studied compared with controls. The cohort with ASD displayed significantly greater
variance in the pooled mean of all compounds compared with controls (p=0.006) and greater
%RSD for seven of the nine xenobiotics included in the variance analysis.

Table 4.2: Quantitative variance
mean by cohort
ASD Cohort
Variance (σ2)
Benzene
0.0089
Toluene
0.085
Xylene
5.9x10-5
Hexane
29
PCE
0.0017
PBDE47
PBDE99
1.3x10-5
Chlorpyrifos
2.5x10-8
Pendimethalin 0.00079
Metolachlor
5.3x10-5
Acetachlor
0.0018
DEHP
11
Total Mean
4.1

and relative standard deviation for each xenobiotic and pooled
%RSD
36
170
57
46
65
50
69
260
140
23
85
290

Control Cohort
Variance (σ2) %RSD
0.0075
30
0.0025
100
3.9
21
0.0040
110
2.3x10-7
33
-5
3.1x10
39
2.2x10-9
267
0.020
700
0.00020
120
0.0054
46
4.7
66
0.87
260

4.3.4 Mean Xenobiotic Body-Burden and Behavioral Severity
All individuals in the ASD cohort scored 7 or higher on total ADOS, meeting the cutoff
for ASD diagnosis. All individuals in the control cohort achieved a score of 6 or less. The
difference in mean scores of the two cohorts on each of the rating scales and observations used in
this study was highly significant.
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No significant correlations were observed between specific

xenobiotic concentrations, MXB, or rating scale performance with age, ethnicity, sex, or socioeconomic status, indicating matched-pairing was statistically irrelevant.
The exclusion criteria for MXB eliminated nine from the ASD cohort and six controls
from this analysis due to insufficient data. Total ADOS performance as a function of MXB for
each individual produced two disparate trends, demonstrated in figure 4.4. The ASD cohort
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(n=21) exhibited a linear trend between increasing MXB and total ADOS performance
(r=0.5384, p=0.011), while the control cohort (n=24) demonstrated no linear trend or correlation
with MXB (r=0.1121, p=0.60). MXB also significantly correlated with the two ADOS subdomains: communication (p=0.020) and social (p=0.050) in the cohort with ASD, but not
controls (p=0.80, p=0.34, respectively). The Pearson correlation, r, is used as a measure of linear
relationship, expressed as a value between -1 and 1. While there is no agreed-upon limit for rvalue significance, researchers have implied that correlations as low as 0.3 demonstrate statistical
significance.38

Figure 4.4: Individual total ADOS performance as a function of mean xenobiotic burden in
serum for ASD cohort and controls, showing the compound class with the greatest relative
contribution to mean
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No other parent questionnaires or rating scales produced significant correlations with
MXB in either cohort. Hexane, PCE, DEHP, and chlorpyrifos concentrations demonstrated the
most significant linear correlations with MXB (p=0.001, 0.008, 0.02, 0.03, respectively). No
individual xenobiotics correlated significantly with total ADOS or ADOS sub-domains.
This experiment was not designed with a large enough sample size, determined by a
power analysis (p=0.80), to accurately determine if mean MXB of the whole ASD cohort
differed significantly from the mean MXB of the total study population. For this type of analysis,
a minimum sample size of 600 would be required, given the mean population MXB, mean ASD
cohort MXB, and standard deviation of the population. Mean MXB of the ASD cohort did not
differ significantly from mean MXB of the controls (p=0.491). Within the ASD cohort, mean
MXB of individuals with total ADOS ≤14 (n=10) were nearly significantly lower (p=0.054)
from those with total ADOS >14 (n=11). Mean MXB of individuals with total ADOS >14 were
significantly greater than the control cohort (p=0.029) and the rest of the ADOS ≤14 studypopulation (n=34, p=0.018), as summarized in figure 4.5.
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Figure 4.5: Comparisons of MXB between differing subgroups, with 95% CI
*, **
Pairs of significantly different means
A logistic regression was performed with four rare-event adjustments, shown in figure
4.6. Using total sample size (n=45), MXB was found to be a predictor variable for probability of
obtaining a total ADOS >14 (O.R. =3.43 [1.14, 10.4]) with a statistically significant overall fit
(p=0.0287, coefficient: 1.23). Adjustments were performed using assumed national prevalence
rates of behaviorally severe autism of 0.5%, 1%, 2%, and 3%. These adjustments do not alter the
O.R. or overall significance of model fit.
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Figure 4.6: Logistic regression showing MXB as a predictive variable for diagnosis in the most
behaviorally severe ADOS classification (total ADOS >14), incorporating adjusted intercept
values for assumed national prevalence of the most behaviorally severe ADOS classification.
4.4 Discussion1
The purpose of this cohort study was to evaluate the differential relationship between
concentrations of organic pollutants and behavioral severity in children with ASD and matched
controls. This study was conducted in association with a broader study also evaluating elemental
and immunological markers. 37, 39 Researchers have suggested that children with ASD may have
dysfunctional cellular-level pathways necessary for removal of xenobiotics from the body,

1

Discussions and conclusions for this work were produced in association with The Children’s Institute of
Pittsburgh and represent a collaborative viewpoint citing, where opinion was not the sole work of this author, either
peer-reviewed literature or the consulting physician associated with this IRB-approved study.
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though concerns have been expressed over the design and methodologies of some studies.

40

The

work discussed here addressed many of these concerns by measuring environmentally relevant
serum-concentrations and used matched controls to investigate relationships between and among
organic pollutants and autism rating scales/observations. Compared with a recent national study,
both cohorts demonstrated significantly elevated concentrations of benzene, toluene, and DEHP,
indicating that serum-concentrations of many of the studied organic pollutants may vary based
on location.36
The hypothesized existence of a physiological/environmental interaction mechanism
contributing to the behavioral phenotype of autism in susceptible individuals cannot be rejected
by this research. Three findings provide support for this hypothesis: quantitative and qualitative
differences in specific organic pollutants, significantly different quantitative variance, and
significantly altered levels of methylcobalamin (MeCbl) in the two cohorts. Evidence of genetic
predisposition or susceptibility was suggested by finding a differential neuro-behavioral response
to MXB between the two cohorts. These findings and their relations to the hypothesized
pathophysiology are explored further.

4.4.1 Detoxification and Methylation Efficacy
Observed neurobehavioral and biochemical differences between the cohorts may be
explained by differential functioning of cellular detoxification pathways that may have led to or
exacerbated central nervous system excitotoxicity, a feature found in autism.

15

The control

cohort displayed a significantly greater serum-concentration of metolachlor, a common pesticide
in Western Pennsylvania. Presuming that children with ASD and controls were exposed to
relatively similar regional environments, the children with ASD may have had greater difficulty
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in moving metolachlor from cells and tissues into the blood. Qualitatively, all PCBs were
detected in a greater percentage of the ASD cohort than controls, suggesting the children with
ASD may have had greater difficulty in metabolizing PCB compounds, removing them from
serum. Previous studies have noted that elevated PCBs can increase intraneuronal calcium and
alter calcium signaling via changes in the ryanodine receptor, which can upset the balance
between

glutamate and GABA neurotransmission, creating central

nervous system

excitotoxicity. 12
Researchers associated with the current study have found significantly greater levels of
methylmalonic acid (MMA) in the cohort with ASD compared with controls. 37 Increased MMA
indicates deficiency in MeCbl, a form of vitamin-B12, contributing to impaired MS function.
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Impaired MS function may have disrupted multiple pathways associated with both detoxification
and methylation in the children with ASD, including dopamine-stimulated PLM necessary for
neuronal synchronization and normal functioning of the central nervous system.
With the exception of metolachlor, no other concentration differences were observed
between the cohorts for specific xenobiotics. However, the ASD cohort displayed significantly
greater variance around the mean of individual organic pollutants, as well as the pooled mean,
compared with controls. This difference in variance further suggests the children with ASD may
have had greater variability in detoxification efficacy compared with controls. The suggested
link between methylation, detoxification, and neuropathology is supported by recent research
finding that brains of individuals with ASD display significantly greater variability in neuronal
synchronization compared with controls. 22
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4.4.2 Genetic Predisposition or Susceptibility
Differing neuro-behavioral trends in relation to MXB were observed in the two cohorts.
The significant correlation between MXB and total ADOS score in the ASD cohort, but not
controls, is a fundamental expectation from the hypothesis of genetic predisposition for
susceptibility to environmental triggers.13 As demonstrated in tables 4.3a and 4.3b, correlations
were observed in neither cohort between mean concentration of specific pollutant and total
ADOS

score.

However,

perchloroethylene,

correlations

chlorpyrofos,

and

were

observed

between

DEHP.

These

correlations

MXB

and

between

hexane,
increasing

concentration of specific pollutants and increasing MXB indicates that these four compounds
were the primary influence on MXB values, though the four compounds themselves suggested
no correlative trend with autism severity.
Table 4.3a: Correlations between xenobiotics and MXB and total ADOS for the ASD cohort

Hexane
PCE
DEHP
Chlorpyrifos
Metolachlor
Pendimethalin
Toluene
Acetachlor
Benzene
Xylene
PBDE47
PBDE99

Correlation with
MXB
r-value p-value
0.77
<0.001
0.55
0.008
0.51
0.02
0.46
0.032
-0.31
0.16
-0.16
0.48
-0.04
0.85
0.088
0.7
-

Correlation with
total ADOS
r-value p-value
0.09
0.69
-0.11
0.61
0.023
0.93
0.29
0.44
0.041
0.84
0.15
0.43
0.16
0.54
0.012
0.95
-
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Table 4.3b: Correlations between xenobiotics and MXB and total ADOS for the control cohort
Correlation with
MXB
r-value
p-value
Hexane
0.57
0.003
PCE
0.399
0.053
DEHP
0.43
0.03
Chlorpyrifos
-0.42
0.036
Metolachlor
-0.02
0.9
Pendimethalin 0.12
0.56
Toluene
0.133
0.53
Acetachlor
0.3
0.14
Benzene
Xylene
PBDE47
PBDE99
-

Correlation with
total ADOS
r-value p-value
-0.19
0.32
-0.21
0.31
-0.06
0.83
-0.34
0.27
-0.012
0.94
-0.27
0.15
-0.18
0.49
-0.18
0.34
-

- Not enough data for correlation calculations
While logistic regression across the study population yielded a significant model using
MXB as a predictor variable for the most severe behavioral classification, disagreement exists on
the national-prevalence of diagnosis. Most studies have reported ASD prevalence-rates of 1 –
2%,
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but robust research has not been conducted on prevalence of the classification of “lower

autism.” Given this uncertainty, four rare-event adjustments were used: 0.5%, 1%, 2%, and 3%
national prevalence, found in figure 4.6.43 These logistic regression results imply that for every 1
μg/g increase in MXB, the probability that an individual would present an ADOS score >14
increased by a factor of 3.4.
The results from this study support the hypothesis that ASD pathophysiology may relate to
interactions between physiology and the chemical environment in genetically susceptible
individuals. However, direct studies of detoxification and methylation systems, along with
neuropathology, and their relationship to chemical xenobiotic levels, are necessary in future
studies. While this study was not designed to use organic pollutant concentrations for medically
diagnostic purposes, these statistically significant results suggest the presence of a cellular-level
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mechanism governing the varying degrees of interaction between physiology and the chemical
environment in children with ASD and controls.

4.5 Conclusion
This study lends further support to the growing body of literature that relates ASD
diagnosis with exposure to environmental pollutants. With the exception of metolachlor, results
indicated the cohorts had statistically similar concentrations of individual organic pollutants
studied; however, the ASD cohort demonstrated a significantly greater range of concentrations.
The results from this study were unique in finding the mean xenobiotic burden of organic
pollutant concentrations to significantly correlate with behavioral severity in children with ASD,
but not controls. The mean xenobiotic burden also significantly correlated with increased risk of
the most behaviorally severe ASD diagnosis across both cohorts with an odds ratio of 3.4. These
results support the hypothesis that a portion of the pathophysiology leading to autism may be
attributable to exposure to organic chemical pollutants. Studies that relate copy number variant
data from oligoarrays, whole exome sequencing, and whole genomic sequencing to efficacy of
methylation and detoxification processes and behavioral phenotype are reasonable next steps in
the evaluation of the hypothesis that environmental triggers contribute to the etiology and
maintenance of autism spectrum disorders.

4.6 Limitation
This work was not intended to, nor do the results, support the hypothesis that the studied
cohorts were exposed to greater amounts of environmental pollutants than other populations.
Likewise, these results do not differentiate between causation and correlation in relation to the
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MXB vs. ADOS findings. The correlation observed in the children with ASD may be a symptom
of a malfunctioning detoxification system or may be more causative in nature. Future studies
should investigate the nature of this relationship. Few studies have quantified non-metabolized
markers of environmental exposure in human blood; therefore, accurate and nationally relevant
blood-concentration data was unavailable for many compounds, specifically chlorinated
pesticides.
Blood serum was the only bodily fluid used for extraction and quantification in this
study. While serum was not used as a proxy for adipose tissue or other fluid, the experimental
variability in serum extractions is well known. To address this inherent variability, SBSE and
IDMS were used, as these methods have been reported in literature as highly reproducible
between and among laboratories. However, standard laboratory practice of extraction of
lipophilic compounds, such as pesticides and PCBs, recommends correcting and standardizing
for the lipid content in the blood of an individual. Lipid correction has been performed in
numerous peer-reviewed and government studies; however, simulation studies have found that
correcting for lipid content has high probability to introduce bias into quantification. In this
study, lipid correction was not performed due to the limited volume of serum available from each
child. Novel analytical methods were developed and optimized to use sample volumes
significantly smaller than typically found in literature, which eliminated the possibility of total
lipids analysis.
The simplistic calculation of MXB has resulted in a variable which should not be viewed
as the only statistical comparison between ADOS and organic pollutant concentration. While
table 4.3a and 4.3b show that no one compound drove the observed increase in MXB, nor did
any single compound correlate with ADOS increase in the children with autism either, it must be
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noted that future analysis of this dataset (as well as future studies) will employ the use of
discriminant analysis and principle component analysis to ascertain any internal structure that
may exist inside of the MXB and ADOS datasets. Likewise, future experimental design may
draw upon the MXB values obtained in this study to decide upon appropriate sample size, given
the power with which researchers hope to discriminate data.
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Chapter 5: Conclusions and Future Research Directions

5.1 Environmental Health Conclusions
The research described within this document produced two novel methods for the
analysis of organic pollutants in blood serum, applicable to environmental analysis. The first
method significantly improved upon existing industry accepted methods for the analysis of
pollutants in serum, while utilizing commonplace methods for organic analyte extraction,
SPME.1 This SPME method was flawed, however, in that immersive extraction was not possible,
contrary to multiple existing peer-reviewed methods present in respected journals. Regardless of
the data in these references, immersive analysis using SPME could not be replicated in this
laboratory. This optimized and validated SPME-IDMS method was the first method of its kind to
correct the inherent variability present in SPME analysis by using the quantitative methodologies
described in EPA Method 6800.2
The second method produced by the work described in this document utilized SBSE as
the primary mode of organic pollutant extraction from blood serum and environmental water
samples. As a technology, SBSE has recently gained wider acceptance in the fields of water and
food analysis, but has not been extensively research for clinical or biological research. The SBSE
method produced in this work, when combined with IDMS, resulted in a significantly superior
method when compared with current industry accepted methods for extraction and
quantification. This S-SBSE-IDMS method was the first of its kind to effectively recover
volatile, semi-volatile, and nonvolatile compounds simultaneously from one sample using one
stir-bar with no additional sample modifications.3 The single stir-bar technique provided
additional opportunity for lengthy stir-bar extractions and irreproducible analyte recovery;
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however, when combined with IDMS as described in EPA Method 6800, many common errorintroducing analytical processes were eliminated.
The developed and optimized S-SBSE-IDMS method was applied to collaborative work
focused on the impact of environmental pollutants on human health.4 The results of this
application have provided invaluable contributions to the fields of exposomics, environmental
human health, and pathophysiological research on autism spectrum disorders. The high quality of
the data produced using the described S-SBSE-IDMS method would be difficult to replicate with
currently accepted techniques for either extraction or quantification. The analytical quality
afforded by SBSE and IDMS have pushed both sensitivity and selectivity to a point at which
environmentally relevant, actionable results can be acquired.
The sourcing and identification of exposure routes for the environmental pollutants found
in the children with ASD must be a significant future research goal. Potential exposure routes
include municipal water, ground water, soil, air, and indoor environment, among many others.
For each of these sampling requirements, unique challenges will be discovered that require
unique but effective solutions. For the standard analysis of wastewater and drinking water, the
developed S-SBSE-IDMS method was successfully applied to unknown samples supplied to this
laboratory as part of a working group to report on and recommend updates to EPA Method 625.
This reported S-SBSE-IDMS method produced data among the highest quality of all 23
participating laboratories. All recommendations on the update to Method 625 will appear in a
peer-reviewed publication based upon the method developed for environmental water analysis
presented in Chapter 3.
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5.2 Method Transfer Conclusions
The methods developed in Chapter 2 and 3 presented feasible solutions to the problems
of method transfer cited in their respective Chapters. Many published analytical methods for
biological analysis have been reported as difficult to replicate in independent laboratories by
analysts or technicians. One of the specific aims of the work described in this document was the
elimination of complex, error introducing sample preparation steps. The results presented in
Chapter 3 suggest that this objective was achieved and the hypothesis that IDMS can be used to
eliminate the necessity for analytical laboratory expertise from all analysts and technicians has
been supported as well.
Much of the quantitative error introduced into sample analysis can be attributed to
imprecise sample preparation. Spiking of isotopes for IDMS prior to all other sample preparation
steps creates a scenario where many analytical steps (dilution volumes, extraction times,
extraction temperatures, etc.) can be imprecise without affecting overall analytical quality, as the
ratio between isotopically labeled and naturally occurring compound in said sample will not be
altered. The results presented in Chapter 3 demonstrate that a highly transferable analytical
method has been created that reduces the influence of analyst skill on overall analytical quality.

5.3 Future Research Outlook for Method Transfer
Future research is required to produce a standard method for the analysis of blood serum
beyond a strictly academic setting. As an example, analytical methods for the analysis of
environmental samples have been standardized for decades by the EPA. These environmental
methods have been designed to produce similar values regardless of the analyst or laboratory
producing the quantitative results. Biochemical measurements must be standardized in a similar
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manner. The ability for any moderately trained analyst to produce high quality analytical data
and similar values compared with the expert analyst is a necessity in this age of increasingly
personalized medical care.
Appendix A described several additional experiments performed to further improve the
quality of analytical method transfer and reduce the time and cost of implementing the S-SBSEIDMS method developed in Chapter 3. The first experiment described in Appendix A focused on
an alternative to venous blood draws from the sample collection process for the quantification of
organic pollutants in blood. The second set of experiments sought to remove the consumableheavy liquid nitrogen cryo-trap process from sample analysis. The final section of Appendix A
presents the hypothesis that IDMS may be used to pre-calibrate SPE columns for the analysis of
biological and environmental samples to remove the isotope spiking procedure from the inlaboratory procedure. These experiments have produced promising results, yet further research
will be necessary to increase validity and robustness.
Venous blood draws can be costly and can introduce unnecessary risk of infection and
biological hazard into laboratory research. More hazardous still, an undergraduate teaching
laboratory would find it exceedingly difficult to gain approval for the analysis of venous blood in
an experimental procedure. Yet, increasingly, recent graduates are gaining employment in
clinical and commercial laboratories where they are expected to handle and analyze blood and
other biological fluids. It was the objective of section A.2 to design an undergraduate teaching
laboratory to minimize the cost and hazards associated with analysis of blood. This objective was
accomplished using the S-SBSE-IDMS method developed in Chapter 3 by allowing students to
analyze microliters their own blood obtained from finger-stick devices. While students reported a
higher investment in learning outcome through analysis of their own blood, further research is
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necessary on the full validation of the finger-stick collection method.5 Particular focus must be
given to the stability of volatile analyte in blood when exposed to ambient air prior to collection
via micropipette. In venous blood collection, blood is transferred immediately from vein to
vacuum-sealed container without ever encountering ambient air. A schematic of the proposed
finger-stick method is provided in figure 5.1. This must be thoroughly researched before a
research-oriented publication is submitted.

Figure 5.1: Schematic of the finger-stick procedure to produce direct analysis of microliters of
whole blood
Trapping of volatilized compounds with liquid nitrogen has been the standard with
SBSE, and SPME before it, since its creation. However, one SBSE-GC/MS system under highuse conditions may consume up to 180 liters of liquid nitrogen per week. This is a significant
consumable. Work was performed to remove the requirement for temperatures associated with
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liquid nitrogen using adsorbent polymers in the GC inlet. The hypothesis of this research was
that adsorbent polymers, contrary to inert surfaces like quartz or glass wool, would provide a
second trapping mechanism and allow the use of higher temperatures. If effective trapping could
occur at approximately 0 °C, then thermoelectric cooling could be used instead. The advantage
of thermoelectric cooling is the significant reduction in consumable waste and the high power
efficiency. This hypothesis was supported by research presented in Section A.3.2, but further
work is necessary to validate these findings. Proper method validation must be performed to
ensure that precise and accurate measurements can be made at these new trapping temperatures
with the new polymer traps. Additionally, work must be performed to ensure that complete
analyte desorption is taking place. While no carry over was observed, irreversible compounds
retention by either the SBSE or inlet liner must be investigated.
The final set of experiments presented in Appendix A hypothesized that traditional SPE
columns could be pre-loaded with isotopes to remove the isotope spiking procedure from the
hands of in-laboratory analysts, effectively transferring the skill of the expert analyst into outside
laboratories.6 This hypothesis was tested using both environmental and toxicological samples
and analytes. While stable quantification was achieved for pesticides in groundwater and illicit
drugs in synthetic urine, further work must be performed to increase on-column stability of
isotopes, possibly by forming a complete seal on the SPE column during storage to prevent
drying. A schematic of the pre-loading process and analytical workflow is provided in figure 5.2.
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Figure 5.2: Broad schematic of total analytical procedure
Further exploration of these hypotheses may result in the generation of a high-quality
analytical method capable of seamless transfer between and among laboratories and analysts.

5.4 Future Research Outlook for Theoretical SBSE Investigations
Appendix B presents findings on the investigation of the mechanisms governing SBSE.
Specifically, an investigation was performed to differentiate between a primarily surfaceadsorption extraction and a bulk-PDMS volume based extraction. Theoretical models on analyte
recovery predicted two scenarios: either the extraction was volume based or the analyte recovery
would increase with increasing surface area. Unfortunately, analyte recovery decreased with
increasing surface area. These results were unexpected. Several theories are proposed and
discussed in Appendix B, but the most reasonable is that stir-bar extraction contains elements of
bulk PDMS shielding an analyte from interaction with the solvent to prevent back-extraction.
This work has much research remaining, however. First, one should utilize a direct mass
spectrometric technique to determine the exact depth of penetration of commonly analyzed
molecules, and how this depth may change based on Kow or volatility. A laser-ablation triple
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quadrupole system may be able to scan along the diameter of a stir-bar cross section following
sample extraction to determine, down to a nanometer, the exact depth of penetration of common
analytes. Secondly, the findings from Appendix B must be replicated using different compounds
to determine the influence of chemical characteristics like analyte structure, functional class,
volatility, molecular weight, and many others.
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Appendix A: Optimizations to Improve Method Transfer

A.1 Introduction
As a primary focus of the research described here within, valid inter-laboratory method
transfer requires that analysts, regardless of individual analyst skill, reproduce an analytical
method with similar analytical quality to the experts who developed said method. To facilitate
improved method transfer, additional work was performed to reduce complex or errorintroducing sample preparation steps and to reduce consumable consumption. The purpose of
this research was to remove very specific method requirement that may introduce difficulty into
analytical method replication by outside laboratories and analysts.
The aims of this additional research were to eliminate the requirement for venous blooddraw from the analysis of organic pollutants in blood, removing the requirement for consumableheavy liquid nitrogen cryo-trapping in the analytical instrumentation, and the development of
pre-calibrated SPE columns to remove the isotope-spiking step from the sample preparation
procedure for environmental and biological samples.

A.2 Finger-stick Blood Draw – Undergraduate Teaching Laboratory
A.2.1 Introduction
The increasing personalization of medicine has resulted in the development of the term
exposomics.1 The field of exposomics combines clinical, environmental, and analytical
chemistries to investigate how one’s personal genetics defines his or her biochemical response to
insult from environmental pollutants.2 Recent studies have linked exposure to specific
environmental agents with an increased risk of developing many non-communicable diseases.3-9

138

These agents, often called persistent organic pollutants (POPs), display common characteristics
including bioaccumulation, environmental persistence, hydrophobicity, and inherent toxicity.10
Emergent research and increasing clinical relevance have elevated the importance of
understanding techniques used to accurately quantify these agents.
Blood and other biological fluids are clinically significant in assessing the environmental
exposure of an individual.11, 12 Quantitative clinical methods for POPs in whole blood and blood
serum have been in use for decades.13 However, existing methods requiring large volumes of
blood are often not feasible for implementation in undergraduate teaching laboratories due to
time required for venous collection, issues in obtaining internal review board (IRB) approval,
cost, and biological hazards. A rapid, sensitive, and highly reproducible quantitative method was
recently developed for the analysis of POPs in microliters of human blood. 14 It was hypothesized
that the optimized method could be adapted for a teaching laboratory by the use of lancet fingersticks in place of venous blood draws.
This method uses a solid-phase extraction technique called stir-bar sorptive extraction
(SBSE), gas chromatography / mass spectrometry (GC/MS), and a direct quantification
alternative to calibration curves called isotope dilution mass spectrometry (IDMS). Using these
analytical techniques will allow undergraduate students to become familiar with modern
analytical methods and, specifically, their application to highly complex biological matrices.

A.2.2 Pedagogical Considerations
Using their own whole blood, students will apply analytical techniques of POPs
quantification and interpret the results to evaluate their individual profile of organic pollutant
concentrations. Students are asked the question, “What is my individual profile of organic
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pollutant concentrations?” and must defend their answer by describing the analytical process
used and summarizing statistical results. Incorporation of biological sample handling,
processing, and analysis provides students with a hands-on analytical experience that is often
missing from undergraduate curricula. While reducing the potential for hazardous exposures, the
use of each student’s own blood also provides a contextualized chemistry education and
motivates a personal investment in learning outcomes.
This laboratory can be used in courses related to or integrating clinical chemistry,
environmental chemistry, and analytical instrumentation, with varying components of data
analysis and statistics. This course is IRB-exempt for educations purposes. Anonymity of
students, both in-class and in reporting results, was strictly maintained. This laboratory is
intended for upper-class undergraduates who have completed traditional analytical courses. This
experiment can be performed as two consecutive 3-hour laboratory sessions, with introductory
and background information presented as a pre-lab in each session or as one separate 1-hour
lecture. The compounds chosen for quantification represent ten commonly investigated
environmental pollutants. The compound list may be altered in accordance to the primary
literature source (see: Experimental Overview). This laboratory was conducted three separate
times in a course module containing six students each. The laboratory contains a mixture of
independent and group work, with each student expected to work individually on sample
preparation, data analysis, statistics, and final lab reports. The method programming and
instrumentation was performed as a group. This laboratory has several specific objectives.
Following completion of this laboratory, students will have:


Defined biological and chemical hazards



Outlined the basic mechanisms and schematics of SBSE, GC/MS, and IDMS
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Applied standard analytical methods to collect and analyze blood samples



Generated mean concentration, precision, limit of quantification, and confidence intervals
for all compounds
Defended their assessment of their personal profile of organic pollutants



A.2.3 Experimental Overview
Blood samples were obtained from students using lancet finger-stick devices and were then
spiked with an isotopic quantification mixture.15 The samples were extracted using SBSE and the
concentrations of POPs were determined using GC-MS analysis and standard data mass
spectrometer analysis software. A standard method of quantification called IDMS was used for
direct, mathematical quantification.16 While specific POPs were chosen for this laboratory, the
source method allows for the use of any of a number of compounds that fall within a the given
range of hydrophobicity and volatility (log Ko/w = 2.3 - 7.5, log vapor pressure = -1 – 7 torr).14
Although students were familiar with basic instrumental and laboratory methods, a
handout and pre-lab component served to contextualize the importance of clinical research (see:
Supplementary Materials: Prelab). Students were instructed to review the referenced primary
literature sources concerning high-sensitivity analytical methods and their application to clinical
research. During laboratory work, the instructor or assistant was with students at all times.

A.2.4 Methods and Instrumentation
A.2.4.1 Reagents and Materials
For these experiments, 98% deuterium-labeled pendimethalin-d5, acetochlor-d11,
metolachlor-d6, benzo[a]pyrene-d12, benzo[k]fluoranthene-d12, dibenz[a,h]anthracene-d14, and
99% deuterium-labeled benzyl butyl phthalate-d-4 and diethylphthalate-d4 were purchased from
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C/D/N Isotopes Inc. (Pointe-Claire, Quebec, Canada). Polydimethyl siloxane (PDMS) stir-bars
(10 mm x 0.5 mm) were obtained from Gerstel (Mülheim a/d Ruhr, Germany). HPLC-grade
acetonitrile (Sigma-Aldrich, St. Louis, MO) and ultrapure (18 ) water were used for reagent
dilution, glassware cleaning, and stir-bar cleaning.

A.2.4.2 Standards Preparation
For each of the 10 isotopically labeled analytes, a stock solution was prepared in
acetonitrile to approximately 500 µg/g. From these stock solutions, a calibration mixture was
prepared in acetonitrile containing each isotopically labeled analyte at a final concentration of
10.0 µg/g.

A.2.4.3 Sampling
An accurately measured blood sample was obtained from each student. Each student used
a new, sterile lancet to pierce his or her sterilized fingertip. A teaching assistant collected the
blood with a pipette and transferred it to a 20 mL sample vial on a tared analytical balance. Up to
three finger-sticks were required to obtain approximately 0.2 g of blood from each student. Three
samples of 0.2 g were required. This process is demonstrated in figure A.1.
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Figure A.1: The lancet finger-stick procedure showing a) the finger-stick using a sterile lancet on
a sterilized finger pad and b) the collection of 0.2 g of blood by a teaching assistant using a
pipette
A.2.4.4 Instrumentation
An accurately measured sample containing whole blood, isotopic calibration mixture,
acetonitrile, and water were extracted using 10 mm x 0.5 mm PDMS stir-bars in 20 mL vials.
Stir-bars were desorbed thermally in the thermal desorption unit (TDU) connected to the GC
inlet at 300 °C under a splitless helium flow of 50 mL/min. Analytes were cryo-trapped using
liquid nitrogen in the GC inlet using programmed-temperature vaporization mode. The analyte
were released from the trap and separated on a 5%-phenyl PDMS column. Mass spectrometric
analysis was conducted using electron ionization with a single quadrupole in select ion mode set
to the quantitative ions found in literature for each compound. Using the provided qualitative
software, peak areas were extracted for each natural and isotopically labeled analyte. Software
developed in-house was used to quantitate each unknown analyte by IDMS. Detailed
instrumental parameters can be found in Supplementary Material: Laboratory Instructions.
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A.2.4.5 Pre-lab Preparation
Prior to the laboratory, each student was assigned a randomized identification number
that was recorded only by the instructor and discarded upon the conclusion of the course.
Students used this number to identify all samples, notebooks, and lab-reports in lieu of a name.
The laboratory was stocked with three lancets per student, three alcohol swabs per student,
antibacterial soap, and sterile drying cloths. Performing this laboratory in two days, the instructor
must provide students with validation data on the specified analytes, as well as mass bias and Ri/n
values for each analyte.

A.2.4.6 Student Procedure
For the first 3-hour laboratory, students prepared each sample, spiking accurate amounts
of isotopic calibrant, acetonitrile, water and one stir-bar into the vial containing the blood
sample. While all samples extracted simultaneously for 60-minutes, students programmed the
method parameters into the GC/MS according to the primary literature source.14 Following
extraction, students removed the stir bar from each sample, rinsed with water, and loaded into the
auto-sampling cartridge of the GC/MS. The analyses were performed by automated sampling
prior to the second day of experiments. During the second 3-hour laboratory, students extracted
peak areas, given natural and isotopic m/z values and performed IDMS and statistical
calculations.
This laboratory provides the option to expand to three experimental days. To expose
students to validation and method development, the validation experiment, as well as mass bias
and Ri/n determinations, could be performed by students prior to the two days of experiments
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described in this work. Details on these experiments can be found in Supplementary Materials:
Laboratory Instructions.

A.2.5 Hazards and Administrative Considerations
The most significant hazards in this laboratory are biological in nature. All students were
required to wear lab coats, gloves, and goggles at all times throughout the first. The teaching
assistant, who was with the students in the laboratory at all times, obtained new, sterile gloves
and pipette tips between sample collections from each student. Each student was required to
sterilize the fingertip with an alcohol swab prior to sampling and to wash his or her hands with
antibacterial soap after bleeding was stopped with a sterile swab. Basic first aid supplies were
available in case of prolonged bleeding. All waste, including swabs, lancets, pipette tips, and
sterile cloths, were deposited into a biological waste container. Upon completion of all sampling,
the laboratory area, including balances and pipettes, was cleaned with a dilute bleach mixture.
Students labeled each vial with their assigned number and were instructed to only handle their
personal vials.
It was stressed to students that the experimental results were non-diagnostic and were
neither intended nor capable of making medical inferences. Students with concerns on the
medical implications of their results were instructed to direct their questions to a medical
professional. To ensure compliance with the IRB of the institution, the students participating in
this experiment remained anonymous by assignment of a computer-generated random number
and were instructed to never place their name on vials, data files, laboratory notebooks, or lab
reports. Any identifiable record linking the identification number of a student with a student
name was destroyed following the conclusion of the course.
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Students were presented with the option to not participate in the lancet finger-sticks and,
instead, would be provided with a synthetically spiked, sterile sample. No student opted out of
the laboratory. Prior to performing these experiments, instructors obtained written consent from
each student, agreeing to participate in the experiment and allowing his or her data to be
published as pooled results for future instructive purposes.

A.2.6 Results and Discussion
In this laboratory, students prepared, extracted, analyzed, and quantified samples of their
own blood taken by lancet finger-sticks. Students performed IDMS and statistical analysis on the
data extracted using the mass spectrometer qualitative software. Concentration data is discussed
as approximate values to maintain anonymity and conform to the IRB. Each POP was detected in
an average of 11 students, with a mean relative standard deviation of 13.3% between replicates
(N=3). Class mean concentrations ranged from < ~0.002 μg/g blood to ~22.0 μg/g blood, with
intra-analyte ranges up to four orders of magnitude. Mean limits of quantification were
calculated by students, with a maximum sensitivity of 2 ng/g whole blood.
Students calculated personal mean concentrations, standard deviations, and 95%
confidence intervals for each analyte, and performed a statistical outlier test of their choosing on
each replicate. Calculations of limits of detection (calculated as 3-to-1 signal-to-noise) and
quantification (calculated as 5-to-1 signal-to-noise) were performed by students for each analyte
by extracting mean signal-to-noise ratios exported from the mass spectrometer qualitative
software. Considering biological variance, the range and pattern of concentrations obtained by
students fell within expected ranges observed in national studies.
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14, 17

Pooled means of these

statistical values obtained from the analysis of samples from students, instructors, and teaching
assistants can be found in table 1.
All reagents and instruments were validated by the instructor using the described
experimental method. As the “true” value was unknown for each POP in the student’s blood,
accuracy was instead discussed by students in the context of the accuracy obtained in the
validation procedure provided by the instructor.
Table A.1: Pooled class-wide means of statistical values calculated by students (all values in
μg/g)
Pesticides
Pendimethalin
Metolachlor
Acetochlor
Aromatic Hydrocarbons
Dibenz[a,h])anthracene
Benzo[a]pyrene
Benzo[k]fluoranthene
Naphthalate
Flurorene
Phthalates
Benzobutyle phthalate
Diethyl Phthalate

Pooled
Concentrationa

%RSD

<LOQ
0.0100
0.100

Nb

Rangea

LODc

LOQd

N/A
10.9
19.4

0
13
11

N/A
0.00900 - 0.0700
0.100- 19.0

0.03
0.00584
0.09

0.05
0.00974
0.15

0.0600
0.500
2.00
<LOQ
<LOQ

18.3
20.3
8.1
N/A
N/A

8
12
12
0
0

0.00700 - 0.0600
0.0100 - 2.00
0.00200 - 12.0
N/A
N/A

0.00444
0.0119
0.00123
0.00401
0.00625

0.00739
0.0198
0.00205
0.00668
0.0104

0.600
5.00

4.06
12.1

12
14

0.00300 - 3.00
0.0100 - 22.0

0.00192
0.0101

0.0032
0.0169

a: Approximate mean concentration was used to maintain anonymity and conform to IRB
b: N refers to the number of students who demonstrated quantifiable amounts of the relevant compound
c: Limit of detection
d: Limit of quantification

Each student, identified with a unique, randomized numbers, demonstrated a unique
pattern of exposure, with two students having no detectable quantities of any of the chosen
POPs. Students prepared individual lab reports that addressed the stated laboratory objectives in
a standard manuscript style (introduction, methods, results, discussion, conclusions). Students
were expected to defend their analytical results based on calculated LOQ, confidence intervals,
and validation data. Presented with the wide range of concentrations seen across the student
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populations, students were provided with an opportunity to think critically on how personal
genetics or environment may play a role in defining the patterns of concentrations observed in
individuals exposed to relatively similar environments.
Robust studies on expected blood-concentrations for many POPs have not been
conducted, but this laboratory demonstrated that finger-stick blood collection can provide
adaquet sample-volume to achieve limits of quantification between 150 – 2 ng/g whole blood, a
similar range to the source-method and national studies.17 Finger-stick blood collections are a
safer and lower-cost alternative to venous blood collections and allow undergraduates to
experience hands-on learning with real biological samples.

A.2.7 Conclusions
This laboratory provided students with a hands-on opportunity to apply existing
methodologies, interpret results, and evaluate their meaning using advanced analytical
techniques. Finger-stick blood collection was used in lieu of venous blood draws to quantify
clinically relevant organic pollutants, while minimizing cost, hazards, and sample handling. This
laboratory included the use of advanced techniques of extraction, chromatography, mass
spectrometry, and direct quantification in an experiment using real biological samples. Students
reported that analysis of their own blood produced a high investment in learning outcome.

A.3 Removing Liquid Nitrogen Cryo-trap from Analytical Method
A.3.1 Introduction
A primary feature of the S-SBSE-IDMS described in Chapter 3 is the trapping of
analytes, after volatilization in the TDU, with liquid nitrogen at -70 °C in the GC inlet.
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Experiments have shown that volatile compounds adsorbed to a SBSE stir-bar tend to volatilize
over the time of the TDU temperature ramp. This slow volatilization creates two problematic
outcomes: irreproducibility of peak shape and size between replicates, and very broad
chromatographic peaks. To address these problems, inert GC inlet liners are used as an area
directly below the TDU schematically where gaseous compounds can be condensed using liquid
nitrogen. This cryo-trap can then be ballistically heated to 300 °C to instantly volatilize all
condensed compounds and introduce them onto the GC column to produce very narrow
chromatographic peaks.
The cryo-trap process requires the use of liquid nitrogen to reach a temperature at which
a high portion of gaseous analytes is condensed from the carrier gas flow coming from the TDU.
In high-volume laboratories, cryo-trapping can use up to 180L of liquid nitrogen per week. This
high rate of nitrogen consumption is both costly and logistically is difficult to coordinate the
delivery of such large volumes of liquid gas to a laboratory on such a variable basis. It was the
hypothesis of this work that the liquid nitrogen cryo-trap could be replaced by a thermoelectric,
Peltier cooling device through the used of GC inlet liners packed with polymeric adsorptive
materials. Inert GC inlet liners reply on one mechanism to trap gaseous molecules: condensation.
However, adsorptive materials may add an additional trapping mechanism via a physical, noncovalent hydrophobic-hydrophobic interaction. The addition of this second trapping mechanism
may allow gaseous molecule to be trapped at temperatures compatible with thermoelectric
cooling: between -10 °C and 23 °C.
The purpose of this work was to investigate the potential for eliminating liquid nitrogen
from the cryo-trapping step of SBSE - thermal desorption. Increasing the trapping temperature
from the -70 °C typically used with inert inlet liners, such as quartz and glass wool, would allow
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the use of a thermoelectric cooling system to reduce the associated maintenance and consumable
costs. Cryo-trapping efficiency experiments were conducted between -70 and +30 °C.

A.3.2 Methods and Materials
Two types of adsorptive inlet liners included in these tests were supplied by Gerstel:
Tenax TA and Carbopack B. The Tenax TA absorbent liners were used at varying cryo-trapping
temperatures between -70 and +30 °C. Operational parameters and optimal trapping
temperatures were determined and carry-over was assessed with method blanks between all
replicate analyses, primarily based on the optimized method found in Chapter 3. The Carbopack
B adsorptive liners were evaluated over these same temperature ranges.
For sample analysis, 8 uL of a 5 ug/mg mixture of representative EPA 625 compounds
(excluding phenolic compounds, as they are incompatible with PDMS Twister bars) were
directly spiked as a liquid into TDU desorption tubes and cryo-focused in the inlet at
temperatures varying between -70 and +30 °C. A TDU primary desorption of 5 minutes at 300
°C and a CIS secondary desorption of 8 minutes at 300 °C were used for all measurements. An
inlet split flow of 100 mL/minute (100:1 split) was used to sweep the trapped compounds from
the inlet to the column. Method blanks were analyzed between every replicate to investigate
potential carry-over. Carbopack B liners were then tested using identical parameters. Using the
determined optimal temperature, the Tenax TA liner was used to test decreasing the split flow to
reduce carrier gas consumption. A 10:1 split was compared to the standard 100:1 ratio.
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A.3.3 Results2
A.3.3.1 Tenax TA Adsorptive Liner
Seven compounds were chosen for comparisons that represented low, medium, and high
boiling point compounds, as well as a representative range of Kow values. Benzene and toluene
represented volatile compounds, trichlorobenzene and naphthalene represented semi-volatile
compounds, and fluorene, hexachlorobenzene, and 4,4-DDD represented nonvolatile (at ambient
conditions) compounds.
The adsorptive liner packed with Tenax TA was found to poorly retain compounds below
-70 °C, the glass transition point of the polymer. A trapping temperature of -10 °C was found to
provide optimum recovery from the spike for all selected compounds. Benzene recovery
plateaued at -20 °C but provided indistinguishably high recovery at -10 °C and below. No
carryover was observed in any of the method blanks. The limits of detection (calculated as 3:1
signal to noise ratio) of all selected compounds using the 100:1 split flow are plotted in figure
A.2.

2

All figures in Results section depict lower limit of detection- the smallest bars indicate
the best performance.
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Figure A.2: Observed LOD values for selected analytes over a cryo-trapping range of -70 °C to
+30 °C using Tenax TA inlet liners
A.3.3.2 Carbopack B Adsorption Liners
The adsorptive liners packed with Carbopack B were found to optimally retain the
selected compounds at +15 °C. Analysis of benzene did not produce consistent peak areas, peak
shape, or retention times above -50 °C. All blanks remained free of carry-over. The determined
limits of detention (3:1 signal to noise) using the Carbopack B filled liners at 100:1 split ratio are
noted in figure A.3.
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Figure A.3: Observed LOD values for selected analytes over a cryo-trapping range of -70 °C to
+30 °C using Carbopack B inlet liners
A.3.3.3 Comparison Carbopack B and Tenax TA with Parameter Optimization
Comparison of spike recovery between Carbopack B and Tenax TA liners found that the
Carbopack B retained a greater amount of medium and high boiling compounds while Tenax TA
performed better for the very volatile analytes (benzene and toluene). These findings are
demonstrated in figure A.4.
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Figure A.4: Comparison of LOD values for selected analytes at the optimal trapping temperature
for both Carbopack B (+15 °C) and Tenax TA (-10 °C) liners
Tenax TA provided the most stable capture and release of compounds from low to high
boiling point and performed optimally at -10 °C, within Peltier cooling range. Using this cryotrapping temperature, the inlet split ratio was successfully decreased down to 10 mL/minute
(10:1) while continuing to prevent carry-over. The 10:1 split ratio also provided significantly
better limits of detection for all compounds resulting in between 20% and 2700% improvement
in sensitivity compared with the 100:1 split. These results indicate that optimal trapping across
all studied analytes should use Tenax TA adsorptive liner trapping at -10 °C with a 10 mL/min
(10:1) inlet flow. Summary of these findings can be found in figure A.5.

154

Figure A.5: A comparison between inlet split ratios using the optimal trapping temperature with
Carbopack B liners
A.3.3.4 Conclusions
Experimental results have found that using a GC inlet liner packed with a polymeric adsorptive
material can improve the efficiency an effectiveness of cryo-trapping such that higher
temperatures may be used to produce optimal method sensitivity. A comparison was conducted
between two common adsorptive-packed liners: Carbopack B and Tenax TA. It was found that,
in comparison with results from Chapter 3, these liners increased the optimal cryo-trapping
temperatures from -70 °C found with typical glass wool or quartz liners to -10 °C for Tenax TA
and +15 °C for Carbopack B. The results for Carbopack B indicate that this polymer may allow
analyte trapping via thermoelectric device in place of liquid nitrogen. The hypothesis that
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adsorptive inlet liners may provide a way to eliminate liquid nitrogen cryo-trapping from the
developed analytical method has been supported by this work.

A.3.3.5 Limitations and Future Work
The sensitivity of high boiling point compounds (>250 °C, fluorene and above) can
theoretically be improved by increasing the temperature of the mass spectrometer source. The
Agilent single quadrupole source has a default upper temperature limit of 250 °C - potentially
causing condensation of high boiling point compounds from the gaseous phase.
Future work in this area should include an analysis incomplete desorption from the inlet
liner. If the selected compounds are not recovered with 100% efficiency during secondary
desorption, this could lead to more-frequent liner replacement. While these experiments
successfully optimized the cryo-trap temperature to be within a Peltier cooling range, further
tests must be done using a Peltier device to ensure that the process is field-ready.

A.4 Pre-calibrated Solid-phase Extraction Columns
A.4.1 Introduction
Implementation of high-quality mass spectrometry-based analytical methods has
improved overall analytical accuracy, precision, and sensitivity attained in routine analyses. 18
Clinical and commercial laboratories have sought validated techniques to improve sensitivity,
reproducibility, and accuracy through improved sample preparation, instrumental methodology,
and quantitative procedures.19,

20

To achieve higher analytical quality, many laboratories have

adjusted analytical emphasis from common techniques, like assays, to higher-accuracy methods,
like mass spectrometric identification and quantification.21 However, without significant training,
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many novel methods requiring complex sample preparation steps may not be replicated with the
same quality by analysts or technicians in independent laboratories.22 The methodological shift
toward higher sensitivity and higher accuracy analytical methods23, 24 has elevated the necessity
for simplified sample preparation techniques reduce the influence of sample preparation steps on
final analytical quality.
Often, quantitative accuracy is negatively impacted by errors introduced by the large
number of highly precise sample preparation steps required in many methods and by inherent
instrumental uncertainty.25,

26

One technique used for reducing the influence of sample

preparation and instrumental uncertainty on final quantitative quality is called isotope dilution
mass spectrometry (IDMS).27 IDMS is a quantification technique involving the spiking of
accurate amounts of isotopically labeled analogs into an unknown sample. Using known isotopic
abundances, concentration and mass of isotopically labeled spike, and mass of the unknown
sample, the concentration of each analyte can be calculated mathematically without the use of
calibration curves. IDMS can correct for many sources of error often associated with extraction,
mass spectrometry, and quantification. These common sources include imprecise sample
preparation, poor extraction reproducibility, sample loss, low analyte recovery, instrumental
drift, matrix effects, and physical or chemical interferences. Much of the error introduced in
sample preparation to change the concentration of natural analyte in a sample will affect the
isotopic analog identically and be corrected in the final IDMS equation.27,

28

By reducing the

influence of common error-introducing analytical steps on final quantitative quality, IDMS is
capable of transferring high accuracy methods between laboratories and analysts with minimal
additional training.29 However, in-laboratory spiking of the isotopically labeled analogs into the
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unknown samples remains a potential source of analytical error when transferring developed
methods using IDMS.
Commonly, laboratories analyzing environmental and forensic samples utilize gas
chromatography / mass spectrometry (GC/MS), liquid chromatography / mass spectrometry
(LC/MS), or the enzyme-linked immunosorbent assay (ELISA).30-32 However, with increased
availability,

many

laboratories

have

begun

adopting

sensitive

and

high-resolution

instrumentation like time-of-flight mass spectrometers (TOF-MS) to eliminate the requirements
of derivatization and chromatography.33,

34

With the advent of highly sensitive analytical

methods, sample cleanup has become an important part of sample preparation to reduce harmful
biological material and to pre-concentrate the analytes of interest.
Solid-phase extraction (SPE) is a sample cleanup and pre-concentration procedure to
isolate analytes of interest from potentially interfering or harmful biological compounds using
primarily hydrophobic interactions and cationic or anionic exchange.35 SPE is often used on
aqueous and biological samples to selectively extract and pre-concentrate analytes prior to
analysis by LC/MS or electrospray ionization (ESI) TOF-MS. It was hypothesized in the
research presented here that modified SPE columns could be pre-calibrated by, prior to analysis
of an unknown sample, the loading of accurately known concentration of isotopically labeled
analogs by highly skilled analysts. Pre-calibrated columns may be useful in transferring
analytical quality between and among laboratories by removing the spiking of isotopically
labeled analogs from the in-laboratory sample preparation, potentially further reducing the
influence of sample preparation on final quantitative quality. This broad analytical process is
diagrammed in figure A.3.
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This research focused on developing a SPE pre-loading method for future
implementation in improving the transfer of high accuracy and precision analytical methods
between and among laboratories. For optimization experiments, the environmentally relevant
pesticide glyphosate was chosen for its high usage rates, analytical difficulty, and inclusion in
national drinking water regulations. Glyphosate is a polar organophosphate pesticide extensively
used in the U.S. for vegetation control. The hydrophilicity and ionic character of this molecule
make quantification in aqueous solution difficult. The U.S. Environmental Protection Agency
(USEPA) has regulated a maximum contaminant limit of glyphosate in drinking water of 0.7
μg/mL.36 Following development, optimization, and validation for the pesticide glyphosate, the
potential forensic applications were explored by analysis of seven drugs of abuse in synthetic
urine. For both glyphosate and the drugs of abuse, experiments were performed to assess
quantitative stability over time to simulate future experiments in which pre-loaded SPE columns
will be shipped to off-site laboratories for analysis.

A.4.2 Experimental
A.4.2.1 Chemicals and Standards
Glyphosate (99% pure) and glyphosate-2-13C (99% pure, 99% enriched) were acquired
from Sigma-Aldrich (St. Louis, MO, USA). Drinking water samples were supplied by Pittsburgh
Municipal Water (Pittsburgh, PA, USA). Heroin, 6-AM, morphine, cocaine, methadone, and
fentanyl analytical standards at certified concentrations of 1.0 mg/mL and codeine analytical
standard at a certified concentration of 100 μg/mL were purchased from Cerilliant (Round Rock,
TX, USA). The deuterium-enriched analogs: heroin-D9, morphine-D3, cocaine-D3, codeine-D3,
methadone-D3, and fentanyl-D5 at certified concentrations of 100 μg/mL and 6-AM-D3 at a
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certified concentration of 1.0 mg/mL were purchased from Cerilliant. Synthetic urine, HPLC
grade methanol, HPLC grade water, Hyclone phosphate buffered saline (PBS), HPLC grade 2propanol, and ammonium hydroxide were purchased from Fisher Scientific (Pittsburgh, PA,
USA). Acetate buffer was prepared using sodium acetate and acetic acid purchased from Fisher
Scientific. Each naturally occurring analyte was prepared in separate stock solutions at 10 μg/mL
for the drugs of abuse and 60 μg/mL for glyphosate in HPLC grade water. For glyphosate, two
solutions were prepared by mass in drinking water: one spiked with 6 μg/mL of glyphosate and
one spiked with 6 μg/mL of glyphosate-2-13C. Two solutions were prepared by mass in synthetic
urine for the drugs: one containing all unlabeled drugs at 40 ng/mL and one containing all
isotopically labeled analogs at 40 ng/mL.

A.4.2.2 Solid-Phase Extraction
For glyphosate experiments, Strata-SAX SPE columns (500 mg bed mass, 6 mL volume)
were purchased from Phenomenex (Torrance, CA, USA) for the analysis of glyphosate in
drinking water. Columns were conditioned per manufacture recommendations with 4.0 mL
HPLC grade methanol and 4.0 mL HPLC grade water. Then, 4.0 mL of drinking water sample
was loaded onto the column and washed with 4.0 mL of HPLC grade methanol. Elution was
performed with 16 mL of a 1:1 solution of acetonitrile and methanol acidified at 6% with formic
acid. All SPE analyses were performed with a negative pressure vacuum chamber at 1 mL/min.
For IDMS quantification, a solution of glyphosate-2-13C in HPLC grade water was loaded onto
the column after conditioning but before the spiked drinking water sample was loaded.
For the drugs of abuse, CSDAU303 (UCT, Bristol, PA) SPE were used for extraction of
drugs from synthetic urine. Columns were conditioned with 2.0 mL of HPLC methanol, 2.0 mL
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HPLC water, and 2.0 mL PBS. Extraction was performed on 4.0 mL synthetic urine spiked with
unlabeled analytes, followed by a wash of 4.0 mL water, 3.0 mL acetate buffer, and 3.0 mL of
methanol. For IDMS experiments, a 4.0 mL aliquot of the isotopically enriched working solution
(phosphate-buffered to pH 6) in synthetic urine was loaded onto the column next. After a two
minute on-column drying period, all extracted compounds were eluted from the column using
11.0 mL ethyl acetate:2-propanol:ammonium hydroxide (84:12:1) solution.

A.4.2.3 ESI-TOF-MS
A Bruker Daltonics microTOF (Billerica, MA, USA) mass spectrometer with an
orthogonal ESI source was experimentally optimized for the analysis of all analytes of interest
and their deuterium-enriched analogues. Samples were infused using the ESI source at a flow
rate of 240 L/hour with a Cole Palmer 74900-00 syringe pump (Vernon Hills, IL). The
experimentally optimized method parameters can be found in the Results section. Quantitative
m/z ions were experimentally found for each labeled and unlabeled analyte. Quantitative ions for
each natural and isotopic compound can be found in table A.2.
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Table A.2: Quantitative ions for each studied analyte and the corresponding exact and measured
masses
Analyte
Glyphosate
Morphine
Codeine
Cocaine
Methadone
6-AM
Fentanyl
Heroin
Glyphosate-2-13C
Morphine-D3
Codein-D3
Cocaine-D3
Methadone-D3
6-AM-D3
Fentanyl-D5
Heroin-D9

Quantitative Ion
C3H7NO5PC17H20NO3+
C18H22NO3+
C17H22NO4+
C21H28NO+
C19H22NO4+
C22H29N2O+
C21H24NO5+
C213C1H7NO5PC17H17D3NO3+
C18H19D3NO3+
C17H19D3NO4+
C21H25D3NO+
C19H19D3NO4+
C22H24D5N2O+
C21H15D9NO5+

Exact Mass (m/z)
168.00618
286.14432
300.15997
304.15488
310.21709
328.15488
337.22799
370.16545
169.01485
289.17031
303.18596
307.18088
313.24308
331.18088
342.27131
379.24343

Measured Mass (m/z)
168.00673
286.15051
300.16225
304.15816
310.22002
328.15521
337.2277
370.16887
169.01455
289.1708
303.18769
307.18249
313.24389
331.1833
342.27417
379.24523

A.4.2.4 SPE Pre-loading
SPE column pre-loading followed the same conditioning and washing procedures for the
separate columns listed in the Solid-Phase Extraction section. For pre-loading, matrix-matched
solutions containing isotopic analogs were extracted and allowed to air-dry for a determined
period prior to extraction of solutions spiked with certified concentrations of unlabeled analytes.
Optimization of pre-loading procedure assessed three methods of storing columns:
allowing columns to air-dry (AD) in an upright position, rinsing the columns with 2 mL of
HPLC grade water (WR) and storing wet with Parafilm sealing both ends of the column, and
rinsing the columns with 2 mL of HPLC grade methanol (MR) and sealing with Parafilm. Two
sample extraction modifications were assessed: decreasing the volume (DV) of the isotopically
labeled solution from 4 mL to 200 μL, and placing an individual frit (IF) approximately 2 cm
above the column packing. Assessment of these techniques followed a reasonable order. The
storage methods were testing first and comparisons were generated between all three. The
optimal method that provided the greatest long-term quantitative stability was used for all future
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analyses. Pre-loaded columns were cold-stored at 15 °C for one week, two weeks, and four
weeks prior to analysis of a solution of drinking water spiked with certified concentrations of
glyphosate. Five replicates we performed for each technique at each time interval.

A.4.2.5 Method Validations
For validation experiments, solutions were prepared by spiking certified standards for
each analyte being studied into either drinking water or synthetic urine matrix by mass. The
appropriate sample preparation was applied (either SPE using the above method or SPE preloading using the above method) and the eluate was analyzed using the above method for ESITOF-MS. Quantification was performed by IDMS. Replicates were performed for all validation
experiments (n=20 for glyphosate by SPE and SPE pre-loading, n=5 for drugs by SPE and SPE
pre-loading). Experimentally obtained values were compared with calculated values at the 95%
confidence level. For assessment of accuracy, an adequate percent error to be achieved by the
method being validated was set at ±10%.

A.4.3 Results
A method for the quantification of glyphosate using ESI-TOF-MS, traditional SPE, and
IDMS quantification were validated by adapting and optimizing existing methods. 27,

37

Validation results using IDMS quantification were compared with calibration data. Various
techniques were assessed for increasing the quantitative stability over time of columns preloaded with glyphosate-2-13C. The optimal pre-loading technique was then validated in drinking
water samples spiked with unlabeled glyphosate analyzed with the pre-loaded SPE columns.
Robustness of the pre-loading method was then assessed for potential forensic application by
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adapting and optimizing the instrumental method for seven drugs of abuse in synthetic urine.
Quantitative stability over time for the SPE pre-loading method was assessed for both
environmental and forensic applications.

A.4.3.1 Optimization of SPE and ESI-TOF-MS
Strata-SAX (Phenominex) columns were used in the experimental optimization of SPE
elution volume and pH. It was found that the optimum efficiency of glyphosate elution occurred
at pH 6.0. Therefore, an eluting solvent consisting of 1:1 acetonitrile/methanol acidified to 6%
formic acid was used. Analysis of eluent fractions determined 16 mL was required to elute the 4
mL of 6 μg/mL solution loaded onto the SPE column.
Instrumental parameters were optimized for signal intensity using negative ionization
ESI-TOF-MS. Experimentally optimized instrumental parameters for drinking water samples
spiked with glyphosate can be found in table 1.

Table A.3: Experimentally optimized mass spectrometry parameters for the quantification of
glyphosate.
Parameter
Ionization Mode
Scan Range
Endplate Offset
Capillary
Voltage
Nebulizer
Dry Gas

Value
Negative
50 - 1000
m/z
-500 V

Parameter
Dry Temperature

Value
200 °C

Capillary Exit
Skimmer 1

-100 V
-40.0 V

+3750 V
0.5 Bar
4.0 L/min

Hexapole 1
Hexapole RF
Skimmer 2

-23.0 V
65 Vpp
-22.0 V

Accurate quantification was attained using isotopic distribution patterns, expected m/z
shift between glyphosate and glyphosate-2-13C, and mass accurate resolution of glyphosate and
glyphosate-2-13C.38 For unlabeled glyphosate, a mean mass accuracy of 3.2 ppm was obtained
with mean deviation of 4.3 ppm. For glyphosate-2-13C, a mean mass accuracy was obtained of
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1.7 ppm with a mean deviation of 4.1 ppm. At 168 m/z, a resolving power of 18,000 m/Δm was
obtained. Mass bias was calculated to determine the differential instrument response between the
natural and isotopically labeled forms of glyphosate. A mass bias factor of 1.0006 was
determined for the IDMS quantification procedure for glyphosate.39 Optimized instrumental
parameters produced the resolved spectra seen in figure A.6.

Figure A.6: Averaged mass spectra (n=7) obtained from the analysis of drinking water spiked
with 50 μg/mL of glyphosate and 50 μg/mL of glyphosate-2-13C showing baseline resolution and
mass accuracy
While high-resolution mass spectrometry (HR-MS) was used for mass accurate
compound identification in this research on simple samples containing known compounds, it has
been reported elsewhere that mass accuracy, even below 1 ppm experimental mass error, is not
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sufficient to accurately identify unknown analytes in samples.40 This research optimized an
instrumental method for the quantification of glyphosate in known samples only as a means of
assessing the developed pre-loading technique and the mass accuracy of 3 ppm was therefore
deemed adequate. This optimized instrumental method would not be suitable for absolute
identification of samples containing unknown compounds.

A.4.3.2 Validation of SPE and ESI-TOF-MS
Instrument limit of quantification (LOQ) of ESI-TOF-MS for glyphosate in drinking
water was found to be 0.312 μg/mL. Method LOQ for ESI-TOF-MS using traditional SPE and
IDMS quantification for glyphosate in drinking water was found to be 0.4010.01 μg/mL. Using
IDMS, the experimentally determined LOQ was found to be equal to the experimentally
determined limit of detection (LOD), confirming previous studies on molecular IDMS
quantification.29 This LOQ sufficiently exceeded the National Primary Drinking Water
Regulations from the USEPA, which specified a maximum glyphosate contaminant level of
0.700 μg/mL.
Drinking water spiked with glyphosate standard at a certified concentration of 6.00
μg/mL was analyzed using the optimized ESI-TOF-MS parameters and the traditional SPE,
quantified using IDMS (n=20). The optimized method produced an experimental concentration
of 5.95±0.08 μg/mL, representing an overall accuracy with 0.83% error and a precision of 1.3%
RSD. These results indicate that a valid, optimized instrumental method was adapted from
previously published sources to provide precise and mass-accurate quantification to be applied to
the assessment of SPE pre-loading techniques.
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A.4.3.3 Comparison of Quantitative Methodologies
Samples spiked with both labeled and unlabeled analytes at concentrations approaching
the LOQ were used to create a calibration curve. Figure A.7 shows calibration data approaching
the determined LOQ as well as the same data treated with IDMS quantification from the same
samples, showing percent error from certified concentration, with 95% confidence intervals, at
various concentrations points (n=5 at each point). Quantitative methodologies were compared
using the validated ESI-TOF-MS method with traditional SPE. Drinking water samples spiked
with certified concentrations of glyphosate were quantified using IDMS with a mean accuracy of
4.22%5.81% error over the concentration range 0.600 – 6.25 μg/mL, losing quantitative
accuracy below 0.401 μg/mL. Calibration curve quantification lost quantitative accuracy at the
95% confidence level at 3.25 μg/mL, exhibited 59.4%43.0% error the studied concentration
range, but remained detectable to a concentration of 0.401 μg/mL. IDMS and calibration curve
quantification demonstrated identical limits of detection, but IDMS produced a significantly
lower LOQ.
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Figure A.7: A comparison of percent error of glyphosate quantification obtained in drinking
water at various concentrations using IDMS and calibration curve quantifications. Dashed black
line indicates certified value and shaded area represents ±5% certified error.
A.4.3.4 Optimization of Pre-loading Method
Samples containing glyphosate-2-13C in drinking water were loaded onto the SPE
columns using the manufacturer recommended procedure. These pre-loaded columns lost
adequate accuracy when used for quantification of spiked drinking water samples after 1 day of
storage. Several optimization procedures were then undertaken to increase on-column stability.
The techniques that meaningfully impacted percent error are summarized in figure A.8, showing
absolute value of percent error using each specified method with 95% confidence intervals.
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Figure A.8: The effects on absolute value of percent error of multiple optimization techniques
after (top) one week of storage and (bottom) two weeks of storage, with 95% confidence
intervals shown
Three techniques of storing SPE columns loaded with glyphosate-2-13C: air-drying
columns (AD), storing with 2 mL water-rinse (WR), and storing with 2 mL methanol-rinse (MR)
were assessed for quantitative stability over time. Two modifications of applying the pre-loading
spikes were assessed: decreasing volume from 4 mL to 200 μL of spiking solution (DV), and
spiking the solution onto an individual frit (IF) above the column packing. Combinations of
storage conditions and pre-loading techniques were assessed in the optimization experiments.
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The optimization experiments were performed using 5 μg/mL of pre-loaded glyphosate-2-13C
and 5 μg/mL of glyphosate (n=5 for each technique).
At one week of storage, AD and WR showed no statistical difference in percent error, but
MR exhibited statistically decreased percent error from both AD and WR (p<0.05). However,
both WR and MR produced disruption of the SPE column packing material, which lead to
irreversible binding of glyphosate-2-13C. Irreversible binding of the pre-loaded isotope was
suspected in WR and MR by the production of large positive bias after storage for two weeks.
Irreversible binding was confirmed by the observation of large negative bias by pre-loading
unlabeled analytes and quantifying a solution of isotopically labeled analytes after two weeks of
storage. Therefore, WR and MR were eliminated from the optimization experiments. The
modified pre-loading procedure of DV+AD significantly reduced percent error compared with
AD, WR, and MR (all p<0.05). The modified pre-loading procedure of IF+DV+AD produced
significantly decreased percent error compared with AD and WR (all p<0.05).
After two weeks of storage, all optimization techniques increased in percent error
compared with the same technique after one week. DV+AD exhibited significantly lower percent
error compared with AD after two weeks of storage (p<0.05), but did not demonstrate adequate
quantitative accuracy (26.6%±1.12% error). IF+DV+AD exhibited further significant decrease in
percent error compared with DV+AD (p<0.05) and maintained adequate quantitative accuracy
(6.41%±7.14% error).
When extended to four weeks of storage, no technique or combination of techniques
yielded adequate quantitative accuracy, with IF+DV+AD exhibiting 47.2%±1.35% error. Results
for IF+DV+AD over four weeks can be found in figure A.9. Significant loss of stability was
observed between two and four weeks for pre-loaded columns. It was determined that the
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combination IF+DV+AD would be used in the pre-loading method to maintain high-quality
quantification up to two weeks after pre-loading. Future research will work to improve the
stability of on-column analyte stability during storage.

Figure A.9: Quantitative stability over time of SPE columns pre-loaded with isotopically labeled
glyphosate. Percent error and 95% confidence errors are shown.
A.4.3.5 Validation of Pre-loading Technique
Using the validated instrumental parameters from the optimized ESI-TOF-MS method
and the IF+DV+AD technique optimized for SPE pre-loading, a validation experiment was
performed on drinking water spiked with 6 μg/mL of glyphosate (n=20). Columns were preloaded with isotopically labeled glyphosate at a concentration of 6 μg/mL 30 minutes prior to
analysis of the spiked drinking water to allow the columns time to air-dry. Drinking water
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samples analyzed 30-minutes after pre-loading columns with isotopes produced a final
concentration of 5.93±0.052 μg/mL, representing a 1.25% error and a 0.87% RSD. A method
LOQ of 0.401 μg/mL was obtained for the pre-loaded columns, identical to the LOQ obtained for
ESI-TOF-MS using traditional SPE. These results indicate that the IF+DV+AD pre-loading
technique produced valid quantitative results that did not differ significantly from either the
certified value or quantitative results from the ESI-TOF-MS method using traditional SPE at the
95% confidence level.

A.4.3.6 Potential Application to Drugs of Abuse in Synthetic Urine
The optimized and validated ESI-TOF-MS analytical method was optimized for the
quantification in synthetic urine of seven common opioids and alkaloids used as adulterants.
Experimentally optimized instrumental parameters can be found in table A.4. Analysis of these
opioid and alkaloid compounds required changing the SPE column from the anion-exchange
column used for glyphosate to a Clean Screen DAU (UCT) mixed-mode hydrophobic and
cation-exchange column.

Table A.4: Experimentally optimized mass spectrometry parameters for the quantification of
opioid and alkaloid drugs of abuse.
Parameter
Ionization Mode
Scan Range
Endplate Offset
Capillary
Voltage
Nebulizer
Dry Gas

Value
Positive
240-400
m/z
-500 V

Parameter
Dry Temperature

Value
200 °C

Capillary Exit
Skimmer 1

135 V
40.0 V

-4500 V
0.4 Bar
4.0 L/min

Hexapole 1
Hexapole RF
Skimmer 2

23.0 V
250 Vpp
24.0 V

The optimized instrumental parameters produced valid quantification for all seven drugs
spiked in synthetic urine at 40 ng/mL following traditional SPE extraction. Validation results for
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ESI-TOF-MS using traditional SPE and IDMS can be found in table A.5 comparing certified
concentrations with experimentally determined concentrations with 95% confidence intervals.
All drugs of abuse were quantified with <10% quantitative error and <20% RSD. Accuracy
ranged from 0.689% to 9.33% error for methadone and cocaine, respectively. Precision ranged
from 0.973% to 11.6% RSD for fentanyl and morphine, respectively. Mean quantitative accuracy
for samples analyzed using ESI-TOF-MS with traditional SPE exhibited mean accuracy of
4.16%±3.07% error and mean precisions of 5.93%±3.03% RSD. Experimentally determined
concentrations did not differ significantly from certified concentrations at the 95% confidence
level.

Table A.5: Validation values for opioids and alkaloids using ESI-TOF-MS, traditional SPE, and
IDMS quantification for drugs of abuse in synthetic urine, showing 95% confidence
SPE-ESI-TOFMS (n=5)
Morphine
Codeine
Cocaine
Methadone
6-AM
Fentanyl
Heroin

Calculated
Value (ng/mL)
40±2.00
40±2.00
40±2.00
40±2.00
40±2.00
40±2.00
40±2.00

Experimental
Value (ng/mL)
42.2±6.65
42.3±4.44
43.7±2.18
39.7±2.32
40.3±0.531
42.4±4.10
42.2±6.65

|%Error|
5.57
5.86
9.33
0.689
0.797
0.710
6.18

%RSD
11.6
7.73
3.69
4.32
6.12
0.973
7.13

LOD (ng/mL)
0.446
0.202
0.773
0.128
0.0502
0.234
0.238

LOQ (ng/mL)
0.800
0.800
0.800
0.800
0.800
0.800
0.800

The method LOQ determined for the drugs of abuse using the optimized ESI-TOF-MS
with traditional SPE and IDMS of 0.780 ng/mL for all analytes. As with the work with
glyphosate, quantification with IDMS produced significantly higher accuracy and precision
approaching the LOQ. In figure A.10, IDMS and typical calibration curve quantitation are
compared in the same samples using the validated ESI-TOF-MS method and traditional SPE,
showing mean percent difference from certified concentrations of all analytes included in this
study at various concentration points, with 95% confidence ranges (n=5). IDMS exhibited a
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mean percent error across all concentration points for all analytes of 5.66%±10.9%. Calibration
curve lost quantitative accuracy below 3.13 ng/mL, exhibiting a mean percent error for the
concentrations range 25.0 ng/mL through 3.13 ng/mL of 11.5%±27.8%.

Figure A.10: A comparison of mean accuracy and precision (95% confidence range) of
experimental values obtained in synthetic urine with calibration curve and IDMS across all listed
analytes. Dashed black line indicates certified value and shaded area representing ±5% certified
error.
*Confidence interval falls outside of viewable range
The IF+DV+AD pre-loading technique was validated for the drugs of abuse using the
mixed-mode SPE column, analyzed by the optimized and validated ESI-TOF-MS instrumental
method. Analysis of synthetic urine spiked with 40 ng/mL of all seven drugs of abuse using preloaded SPE columns 30-minutes after pre-loading produced highly accurate quantitative results.
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All opioids and alkaloids with the exception of cocaine were quantified with ≤10% quantitative
error and <20% RSD. Accuracy ranged from 0.766% to 13.0% error for codeine and cocaine,
respectively. A mean accuracy of 5.36%±4.73% error and mean precision of 6.58%±2.92% RSD
were produced by the pre-loading method. The mean experimental values obtained did not differ
from the mean certified values or from the concentrations obtained using the validated ESI-TOFMS and traditional SPE method at the 95% confidence level. Validation results for the
quantification of all seven opioids and alkaloids spiked in synthetic urine and extracted using
pre-loaded SPE columns 30 minutes after pre-loading can be found in table A.6.

Table A.6: Validation values for opioids and alkaloids using ESI-TOF-MS, SPE pre-loading
method, and IDMS quantification in synthetic urine, showing 95% confidence
Pre-loading
(n=5)
Morphine
Codeine
Cocaine
Methadone
6-AM
Fentanyl
Heroin

Calculated
Value (ng/mL)
40±2.00
40±2.00
40±2.00
40±2.00
40±2.00
40±2.00
40±2.00

Experimental
Value (ng/mL)
40.6±1.61
39.7±3.40
34.8±5.07
44.0±6.23
39.4±1.87
40.3±4.49
36.2±1.94

|%Error|
1.59
0.766
13.0
10.0
1.56
0.873
9.52

%RSD
2.93
6.32
10.1
10.4
3.43
8.21
3.95

LOD (ng/mL)
0.429
0.214
0.737
0.156
0.0552
0.222
0.223

LOQ (ng/mL)
0.8
0.8
0.8
0.8
0.8
0.8
0.8

Using the ESI-TOF-MS instrumental method and the IF+DV+AD pre-loading method,
stability over time was assessed for the analysis of synthetic urine samples spiked with the drugs
of interest. Morphine, codeine, methadone, 6-acetylmorphine, and fentanyl were quantified with
adequate accuracy when analyzed one week after column pre-loading. Methadone, fentanyl, and
codeine maintained adequate quantitative accuracy when quantified two weeks after column
loading. At the two-week time interval, codeine maintained accuracy at the 95% confidence
interval, but produced poor precision (±12%). Cocaine and heroin were not quantified accurately
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after one week (15%, 17% error, respectively) or after two weeks (15%, 25% error, respectively)
of storage. The stability over time results are summarized in figure A.11.

Figure A.11: Mean %error of pre-loaded columns after storage for indicated amounts of time,
showing 95% confidence intervals. Dashed line represents the 10% error from certified value
defined as adequate accuracy in this study.
The work presented here demonstrates the viability of isotopically pre-loaded SPE
columns for the quantification of environmentally and forensically relevant analytes by IDMS.
This viability was demonstrated with different SPE column packing types and a wide range of
investigate analytes. While the pre-loading technique did not remain stable quantitative accuracy
over time for all chosen drugs of abuse, the concept of pre-loading and storing SPE columns for
future analysis has been proven viable by this research. Future work will increase the breadth and
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robustness of this developed method. In subsequent research, the transfer of analytical quality
using this pre-loading method will be tested in by shipment of pre-loaded SPE columns to
independent laboratories for quantification of determined analytes. Providing analysts with precalibrated, pre-loaded SPE columns to be used for IDMS quantification may help to improve
overall analytical quality.

A.4.4 Conclusions
This research has demonstrated viability of modifying SPE columns to produce precalibration by loading columns with accurately known concentrations of isotopically labeled
analogs to remain quantitatively stable over a necessary amount of time. The method for column
pre-loading was developed, optimized, and validated for quantification of the organophosphate
pesticide glyphosate in drinking water. This pre-loading method was then adapted and applied to
a different column packing material for the quantification of seven drugs of abuse in synthetic
urine. The pre-loading method was shown to be highly quantitatively stable over a period of two
weeks for glyphosate and one week for all drugs of abuse, excluding cocaine and heroin. This
work is useful to researchers seeking to develop methods to improve the transfer of high
accuracy and precision analytical methods between and among laboratories. Future work will be
conducted on further increasing the on-column stability of analytes, increasing the breadth of
applicable analytes and columns, and evaluation of field-deployment into off-site laboratories.
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Appendix B: Investigation of Stir-bar Sorptive Extraction Mechanism
B.1 Introduction
The large extraction-phase volume permitted by the stir-bar design allows highly efficient
analyte recovery to be achieved for appropriately hydrophobic molecules (measured by the
octanol / water partition coefficient Kow). The well-accepted mechanism for analyte recovery via
SBSE states that analyte recovery will increase as the volume of extraction phase is increased,
relative to the volume of sample. The equations describing the recovery of an analyte from an
aqueous solution into a PDMS stir bar are:

%Recovery = Ko/w / (Ko/w + β)

eq. B.1

β = Volumesample / VolumePDMS

eq. B.2

Where, Ko/w is the octanol-water partition coefficient of a compound of interest and β is
the phase-ratio between the sample and stationary phase of the extraction media. It is an accepted
point in literature that by simply altering the phase-ratio by increasing the volume of PDMS in
the stationary phase, a greater amount of an analyte may be recovered (when keeping all other
variables unaltered). It was the hypothesis of this research, however, that describing analyte
recovery from an aqueous solution by phase-ratio alone is not an accurate method of describing
the extraction mechanism. This research sought to investigate the influence of surface adhesion
on the total recovery of a compound from solution. It has been noted in literature that surface
adsorption of analytes may play a small role in total extraction, but experiments have never
verified this claim.
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An environmentally relevant molecule with relatively low Kow was used to explore the
extraction mechanism in a quantitative manner. Three stir bars were each modified three times
by removing extraction polymer, creating bars with differing surface area by identical volume
compared with one another at each point. Differences in analyte recovery in the three modified
stir-bars were compared with theoretical models that presumed a volume-only extraction
mechanism. This experimental scheme is outlined in figure B.1.

Figure B.1: Schematic of the three stir bar scenarios that produced equal PDMS volume but
different PDMS surface area at four distinct points
B.2 Experimental Design
Method parameters found in Chapter 3 were used for this research. Peer-reviewed SSBSE-IDMS methods were utilized for the quantification of naphthalene in deionized water. The
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experimental design focused on minimizing variability between measurements. To obtain the
most consistent and precise results, as theoretical models predicted a relatively small difference
between three stir bars, care was taken to perform all method procedures identically between
replicates and between stir-bars. Stir-bar extraction time was 60-minutes, measured by a
stopwatch. Sample preparation was timed to assure that no dramatic differences were introduced
during sample preparation. All analyte spiking and dilution procedures were conducted by mass
on an analytical balance. Calculated concentration for every sample was normalized to produce a
consistent value for every analysis by using the minor deviations in mass of analyte spike to
correct to a standard value. Between all samples, an instrumental blank was run to ensure no
carry-over effect was present. Similarly, after each analysis, every stir bar was analyzed a second
time to ensure that the analytes were completely desorbed. PDMS was removed at each point
using a new razor blade, weighing each bar before and after removal. New, conditioned stir-bars
were used to avoid discrepancies between the surfaces of used stir-bars. Stir-bars were cleaned
thermally between each replicate for 3 hours at 300 °C. Between points, following removal of
PDMS, stir-bars were conditioned in solvent as recommended by the manufacturer and then
thermally cleaned for 3 hours at 300 °C. All points were calculated as a “normalized mean peak
area” in that the mean peak area at a given point for a given bar was plotted as a fraction of the
peak area of the unmodified stir-bar.

B.3 Results
Using the extraction recovery equation, the volume of extraction phase PDMS was
theoretically decreased while holding solution volume and analyte Kow constant. Figure B.2
shows the two expected scenarios. Expected results gave two options: a. if the stir bars obeyed a
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PDMS volume-dependent extraction mechanism, all three stir-bar modifications would produce
the same recovery as PDMS was removed (black line). Or, b. if the stir-bars obeyed a surface
area-dependent extraction mechanism, three distinct recovery curves would be observed (blue,
red, green). Log(Kow) of 3 was chosen to yield the highest quality results. Experimentally,
compounds of higher Kow tended to be extracted at ~100% recovery as nearly all PDMS was
removed. Compounds of lower Kow tended to be extracted with poor precision.

Figure B.2: Theoretical recovery of compound with log(Kow) = 3 from 10 mL solution using
10mm stir bar, showing variable effect of removing increasing amounts of PDMS

Experimental results indicate that, over all PDMS-removed points, the stir bar with the
least surface area extracted the most naphthalene. These results are demonstrated in figure B.3.
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The extraction of naphthalene appears to have been surface area-dependent. However, the results
disagree with theoretical expectations. The stir bar with the largest surface area recovered the
least amount of naphthalene, all other variables held constant. N = 3 at each point and 95%
confidence intervals shown.

Figure B.3: Recovery trend of naphthalene from three stir bars of varying surface area as a
function of mass of PDMS removed, 95% confidence shown
Comparing the amount of naphthalene recovered in stir bars with identical masses of
PDMS removed produced statistically significant differences between each bar (n=3). Figure B.4
provides a focused comparison between the recovery of all three stir-bars, keeping all other
variables constant. Recovery was statistically unique for each bar, with recovery decreasing with
increased surface area. N = 3 and 95% confidence shown.
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Figure B.4: Comparison of naphthalene recovery between three stir bars, at identical volumes of
PDMS, 95% confidence shown
B.4 Conclusions
An experiment was conducted to investigate the mechanisms governing stir-bar sorptive
extraction. It was hypothesized that increasing the surface area-to-volume ratio of a stir bar could
increase the analyte recovery at extraction equilibrium. Theoretical models agreed with this, but
experimental results revealed a trend between increasing surface area of a stir bar and decreasing
recovery at extraction equilibrium. This effect may be explained by stir-bars with lower surface
area-to-volume ratios allowing analytes to penetrate into the PDMS bulk, isolated from the
solution matrix. Bars with greater surface area-to-volume ratios may permit more surfaceadhesion and greater analyte-solvent contact, thereby allowing greater back-extraction into
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solution. This hypothesis will be investigated in future work using laser-ablation to probe the
depth of PDMS penetration.
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